{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 714210, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:42:02Z", "timestamp": 1574134922232}, "reference-count": 12, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1996, 5, 1]], "date-time": "1996-05-01T00:00:00Z", "timestamp": 830908800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nat Genet"], "published-print": {"date-parts": [[1996, 5]]}, "DOI": "10.1038/ng0596-117", "type": "journal-article", "created": {"date-parts": [[2004, 8, 18]], "date-time": "2004-08-18T20:12:15Z", "timestamp": 1092859935000}, "page": "117-119", "source": "Crossref", "is-referenced-by-count": 296, "title": ["A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes"], "prefix": "10.1038", "volume": "13", "author": [{"given": "Steinunn", "family": "Thorlacius", "sequence": "first", "affiliation": []}, {"given": "Gudridur", "family": "Olafsdottir", "sequence": "additional", "affiliation": []}, {"given": "Laufey", "family": "Tryggvadottir", "sequence": "additional", "affiliation": []}, {"given": "Susan", "family": "Neuhausen", "sequence": "additional", "affiliation": []}, {"given": "Jon G.", "family": "Jonasson", "sequence": "additional", "affiliation": []}, {"given": "Sean V.", "family": "Tavtigian", "sequence": "additional", "affiliation": []}, {"given": "Hrafn", "family": "Tulinius", "sequence": "additional", "affiliation": []}, {"given": "Helga M.", "family": "\u00d6gmundsdottir", "sequence": "additional", "affiliation": []}, {"given": "Jorunn E.", "family": "Eyfj\u00f6rd", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BFng0596117_CR1", "doi-asserted-by": "publisher", "first-page": "544", "DOI": "10.1016/S0140-6736(95)91383-1", "volume": "346", "author": "S Thorlacius", "year": "1995", "unstructured": "Thorlacius, S. et al. Linkage to BRCA2 region in hereditary male breast cancer. Lancet 346, 544\u2013545 (1995).", "journal-title": "Lancet"}, {"key": "BFng0596117_CR2", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1038/ng0396-333", "volume": "12", "author": "S Tavtigian", "year": "1996", "unstructured": "Tavtigian, S. et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet. 12, 333\u2013337 (1996).", "journal-title": "Nature Genet."}, {"key": "BFng0596117_CR3", "doi-asserted-by": "publisher", "first-page": "789", "DOI": "10.1038/378789a0", "volume": "378", "author": "R Wooster", "year": "1995", "unstructured": "Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789\u2013792 (1995).", "journal-title": "Nature"}, {"key": "BFng0596117_CR4", "doi-asserted-by": "publisher", "first-page": "446", "DOI": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X", "volume": "65", "author": "JG Jonasson", "year": "1996", "unstructured": "Jonasson, J.G., Agnarrson B.A., Thorlacius, S., Eyfjord, J.E. & Tulinius, H. Male breast cancer in Iceland. Int. J. Cancer 65, 446\u2013449 (1996).", "journal-title": "Int. J. Cancer"}, {"key": "BFng0596117_CR5", "author": "DM Parkin", "first-page": "618", "year": "1992", "unstructured": "Parkin, D.M., Muir, C.S., Whelan, S.L., Gao, Y.T., Ferlay, J. & Powell, J. in Cancer incidence in five continents. VI, 618\u2013621 (IARC, Lyon, 1992).", "volume-title": "Cancer incidence in five continents."}, {"key": "BFng0596117_CR6", "doi-asserted-by": "publisher", "first-page": "198", "DOI": "10.1038/ng1095-198", "volume": "11", "author": "JR Struewing", "year": "1995", "unstructured": "Struewing, J.R. et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet. 11, 198\u2013200 (1995).", "journal-title": "Nature Genet."}, {"key": "BFng0596117_CR7", "doi-asserted-by": "publisher", "first-page": "657", "DOI": "10.3109/02841869509094044", "volume": "34", "author": "RB Barkardottir", "year": "1995", "unstructured": "Barkardottir, R.B., Arason, A., Egilsson, V., Gudmundsson, J., Jonasdottir, A. & Johannesdottir, G. Chromosome 17q-linkage seems to be infrequent in Icelandic families at risk of breast cancer. Acta Oncol. 34, 657\u2013662 (1995).", "journal-title": "Acta Oncol."}, {"key": "BFng0596117_CR8", "doi-asserted-by": "publisher", "first-page": "5950", "DOI": "10.1073/pnas.92.13.5950", "volume": "92", "author": "M Schutte", "year": "1995", "unstructured": "Schutte, M. et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA 92, 5950\u20135954 (1995).", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "BFng0596117_CR9", "doi-asserted-by": "publisher", "first-page": "982", "DOI": "10.1136/jmg.32.12.982", "volume": "32", "author": "P Tonin", "year": "1995", "unstructured": "Tonin, P. et al. A large multisite cancer family is linked to BRCA2. J. Med. Genet. 32, 982\u2013984 (1995).", "journal-title": "J. Med. Genet."}, {"key": "BFng0596117_CR10", "author": "OK Wright", "first-page": "153", "year": "1990", "unstructured": "Wright, O.K. & Manos, M. Sample preparation from paraffin-embedded tissues, in PCR Protocols; A Guide to Methods and Applications, (eds Innis, MA, Gelfand, D. H., Sninsky, J.J. & White, T.J.) 153\u2013158 (Academic Press, San Diego, 1990).", "volume-title": "PCR Protocols; A Guide to Methods and Applications"}, {"key": "BFng0596117_CR11", "first-page": "1637", "volume": "53", "author": "S Thorlacius", "year": "1993", "unstructured": "Thorlacius, S., Borresen, A.L. & Eyfjord, J.E. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res. 53, 1637\u20131641 (1993).", "journal-title": "Cancer Res."}, {"key": "BFng0596117_CR12", "first-page": "460", "volume": "36", "author": "GM Lathrop", "year": "1984", "unstructured": "Lathrop, G.M. & Lalouel, J.M. Easy calculations of lod scores and genetic risk on small computers. Am. J. Hum. Genet. 36, 460\u2013465 (1984).", "journal-title": "Am. J. Hum. Genet."}], "container-title": ["Nature Genetics"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/ng0596-117", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/ng0596-117.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/ng0596-117.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 12, 30]], "date-time": "2018-12-30T21:26:36Z", "timestamp": 1546205196000}, "score": 69.790596, "issued": {"date-parts": [[1996, 5]]}, "references-count": 12, "journal-issue": {"published-print": {"date-parts": [[1996, 5]]}, "issue": "1"}, "alternative-id": ["BFng0596117"], "URL": "http://dx.doi.org/10.1038/ng0596-117", "relation": {"cites": []}, "ISSN": ["1061-4036", "1546-1718"], "issn-type": [{"value": "1061-4036", "type": "print"}, {"value": "1546-1718", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:02:56Z", "timestamp": 1574535776877}, "reference-count": 18, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 8, 18]], "date-time": "2011-08-18T00:00:00Z", "timestamp": 1313625600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2011, 12]]}, "DOI": "10.1007/s10549-011-1733-6", "type": "journal-article", "created": {"date-parts": [[2011, 8, 17]], "date-time": "2011-08-17T15:54:47Z", "timestamp": 1313596487000}, "page": "1057-1061", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families"], "prefix": "10.1007", "volume": "130", "author": [{"given": "S. L.", "family": "Harvey", "sequence": "first", "affiliation": []}, {"name": "kConFab Investigators", "sequence": "first", "affiliation": []}, {"given": "R. L.", "family": "Milne", "sequence": "additional", "affiliation": []}, {"given": "S. A.", "family": "McLachlan", "sequence": "additional", "affiliation": []}, {"given": "M. L.", "family": "Friedlander", "sequence": "additional", "affiliation": []}, {"given": "K. E.", "family": "Birch", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Weideman", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Goldgar", "sequence": "additional", "affiliation": []}, {"given": "J. L.", "family": "Hopper", "sequence": "additional", "affiliation": []}, {"given": "K. A.", "family": "Phillips", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 8, 18]]}, "reference": [{"issue": "5\u20136", "key": "1733_CR1", "first-page": "542", "volume": "112", "author": "CL Scott", "year": "2003", "unstructured": "Scott CL, Jenkins MA, Southey MC, Davis TA, Leary JA, Easton DF, Phillips KA, Hopper JL (2003) Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. Hum Genet 112(5\u20136):542\u2013551", "journal-title": "Hum Genet"}, {"issue": "43", "key": "1733_CR2", "doi-asserted-by": "crossref", "first-page": "5898", "DOI": "10.1038/sj.onc.1209879", "volume": "25", "author": "AC Antoniou", "year": "2006", "unstructured": "Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898\u20135905", "journal-title": "Oncogene"}, {"issue": "2", "key": "1733_CR3", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1200/JCO.2007.11.0262", "volume": "26", "author": "SJ Dawson", "year": "2008", "unstructured": "Dawson SJ, Price MA, Jenkins MA, McKinley JM, Butow PN, McLachlan SA, Lindeman GJ, Weideman P, Friedlander ML, Hopper JL, Phillips KA (2008) Cancer risk management practices of noncarriers within BRCA1/2 mutation\u2013positive families in the Kathleen Cuningham Foundation Consortium for research into familial breast cancer. J Clin Oncol 26(2):225\u2013232", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "1733_CR4", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1136/jmg.2006.043091", "volume": "44", "author": "A Smith", "year": "2007", "unstructured": "Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, Iddenden R, Woodward ER, Lalloo F, Maher ER, Evans DG (2007) Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 44(1):10\u201315", "journal-title": "J Med Genet"}, {"issue": "9", "key": "1733_CR5", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1097/01.gim.0000187155.63849.85", "volume": "7", "author": "TM Allweis", "year": "2005", "unstructured": "Allweis TM, Sagi M, Peretz T (2005) Sporadic breast cancer among relatives of BRCA mutation carriers. Genet Med 7(9):655\u2013656", "journal-title": "Genet Med"}, {"issue": "4", "key": "1733_CR6", "doi-asserted-by": "crossref", "first-page": "e76", "DOI": "10.1136/jmg.2006.048462", "volume": "44", "author": "J Gronwald", "year": "2007", "unstructured": "Gronwald J, Cybulski C, Lubinski J, Narod SA (2007) Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling. J Med Genet 44(4):e76", "journal-title": "J Med Genet"}, {"issue": "8", "key": "1733_CR7", "first-page": "e86", "volume": "44", "author": "D Goldgar", "year": "2007", "unstructured": "Goldgar D, Venne V, Conner T, Buys S (2007) BRCA phenocopies or ascertainment bias? J Med Genet 44(8):e86 author reply e88", "journal-title": "J Med Genet"}, {"issue": "8", "key": "1733_CR8", "first-page": "e89", "volume": "44", "author": "E Rowan", "year": "2007", "unstructured": "Rowan E, Poll A, Narod SA (2007) A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers. J Med Genet 44(8):e89 author reply e88", "journal-title": "J Med Genet"}, {"issue": "2", "key": "1733_CR9", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1007/s10549-009-0611-y", "volume": "119", "author": "SM Domchek", "year": "2010", "unstructured": "Domchek SM, Gaudet MM, Stopfer JE, Fleischaut MH, Powers J, Kauff N, Offit K, Nathanson KL, Robson M (2010) Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Res Treat 119(2):409\u2013414", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "1733_CR10", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1007/s10549-010-0923-y", "volume": "125", "author": "LA Korde", "year": "2011", "unstructured": "Korde LA, Mueller CM, Loud JT, Struewing JP, Nichols K, Greene MH, Mai PL (2011) No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families. Breast Cancer Res Treat 125(1):169\u2013173", "journal-title": "Breast Cancer Res Treat"}, {"key": "1733_CR11", "unstructured": "Kathleen Cuningham Consortium for Research into Familial Breast Cancer: kConFab. Online resource. http://www.kconfab.org"}, {"issue": "1", "key": "1733_CR12", "doi-asserted-by": "crossref", "first-page": "R12", "DOI": "10.1186/bcr1377", "volume": "8", "author": "GJ Mann", "year": "2006", "unstructured": "Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12", "journal-title": "Breast Cancer Res"}, {"issue": "2", "key": "1733_CR13", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1007/s10689-004-6129-x", "volume": "4", "author": "KA Phillips", "year": "2005", "unstructured": "Phillips KA, Butow PN, Stewart AE, Chang JH, Weideman PC, Price MA, McLachlan SA, Lindeman GJ, McKay MJ, Friedlander ML, Hopper JL (2005) Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 4(2):105\u2013113", "journal-title": "Fam Cancer"}, {"key": "1733_CR14", "unstructured": "AIHW (2010) In: Welfare AIoHa (ed) ACIM (Australian Cancer Incidence and Mortality) books. AIHW Australian Government, Canberra. http://www.aihw.gov.au/acim-books/"}, {"issue": "6", "key": "1733_CR15", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1016/S0959-8049(00)00023-X", "volume": "36", "author": "PD Pharoah", "year": "2000", "unstructured": "Pharoah PD, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BA (2000) Familial predisposition to breast cancer in a British population: implications for prevention. Eur J Cancer 36(6):773\u2013779", "journal-title": "Eur J Cancer"}, {"issue": "3", "key": "1733_CR16", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1111/j.1369-7625.2008.00494.x", "volume": "11", "author": "AD Bakos", "year": "2008", "unstructured": "Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH (2008) BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Health Expect 11(3):220\u2013231", "journal-title": "Health Expect"}, {"key": "1733_CR17", "unstructured": "Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R; SEARCH collaborators, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Sch\u00fcrmann P, D\u00f6rk T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, kConFab, AOCS Management Group, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies multiple breast cancer susceptibility loci. Nature 447(7148):1087\u20131093"}, {"issue": "12", "key": "1733_CR18", "doi-asserted-by": "crossref", "first-page": "1042", "DOI": "10.1016/S1470-2045(07)70348-0", "volume": "8", "author": "HA Katki", "year": "2007", "unstructured": "Katki HA, Gail MH, Greene MH (2007) Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families. Lancet Oncol 8(12):1042\u20131043", "journal-title": "Lancet Oncol"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10549-011-1733-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s10549-011-1733-6/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-011-1733-6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:33:52Z", "timestamp": 1559234032000}, "score": 41.642254, "issued": {"date-parts": [[2011, 8, 18]]}, "references-count": 18, "journal-issue": {"published-print": {"date-parts": [[2011, 12]]}, "issue": "3"}, "alternative-id": ["1733"], "URL": "http://dx.doi.org/10.1007/s10549-011-1733-6", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T23:50:24Z", "timestamp": 1575157824642}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "S2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 6, 1]], "date-time": "2005-06-01T00:00:00Z", "timestamp": 1117584000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res"], "published-print": {"date-parts": [[2005, 6]]}, "DOI": "10.1186/bcr1089", "type": "journal-article", "created": {"date-parts": [[2005, 6, 25]], "date-time": "2005-06-25T18:13:29Z", "timestamp": 1119723209000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families"], "prefix": "10.1186", "volume": "7", "author": [{"given": "S", "family": "Ciernikov\u00e1", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Tomka", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Kovac", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Stevurkova", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Bella", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Novotny", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Zajac", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 6, 17]]}, "container-title": ["Breast Cancer Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/bcr1089.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/bcr1089/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr1089.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 1, 18]], "date-time": "2017-01-18T15:15:14Z", "timestamp": 1484752514000}, "score": 40.981308, "issued": {"date-parts": [[2005, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 6]]}, "issue": "S2"}, "alternative-id": ["1087"], "URL": "http://dx.doi.org/10.1186/bcr1089", "ISSN": ["1465-542X"], "issn-type": [{"value": "1465-542X", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"], "article-number": "P1.02"}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T07:41:55Z", "timestamp": 1575186115329}, "reference-count": 26, "publisher": "Cambridge University Press (CUP)", "issue": "9", "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2005, 11, 7]], "date-time": "2005-11-07T00:00:00Z", "timestamp": 1131321600000}, "delay-in-days": 67, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Online"], "published-print": {"date-parts": [[2005, 9]]}, "abstract": "<jats:p>Chemoprevention with tamoxifen and oophorectomy are thought to be effective in decreasing the incidence of breast cancer in women at increased risk for the disease. There is mounting data supporting the idea that hormonal interventions that reduce estrogen exposure to breast epithelium, such as prophylactic oophorectomy and tamoxifen, are effective in breast cancer prevention in both BRCA1 and BRCA2 mutations carriers. Several recent studies directly address the protective effect of tamoxifen and oophorectomy in BRCA mutation carriers and suggest that these endocrine manipulations decrease the risk of primary and secondary breast cancers. Ongoing studies aim to better define the effect of tamoxifen in these very high-risk women and determining whether factors, such as earlier age of use or prior prophylactic oophorectomy, impact tamoxifen's effect. Based on existing data, we recommend that women with deleterious mutations in BRCA1 or BRCA2 be informed of the beneficial effect of oophorectomy on breast cancer risk and that women who choose breast cancer screening instead of prophylactic mastectomy be offered tamoxifen as a prevention option.</jats:p>", "DOI": "10.1017/s1470903105002890", "type": "journal-article", "created": {"date-parts": [[2005, 11, 8]], "date-time": "2005-11-08T14:32:55Z", "timestamp": 1131460375000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Update on chemoprevention in BRCA1 and BRCA2 mutation carriers"], "prefix": "10.1017", "volume": "8", "author": [{"given": "M.", "family": "Stumacher", "sequence": "first", "affiliation": []}, {"given": "S. M.", "family": "Domchek", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2005, 11, 7]]}, "reference": [{"key": "S1470903105002890_ref020", "unstructured": "Kauff ND , Satagopan JM , Robson ME , et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. New Engl J Med 2002; 346: 1609\u20131615.", "DOI": "10.1056/NEJMoa020119", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref014", "unstructured": "Lynch BJ , Holden JA , Buys SS , Neuhausen SL , Gaffney DK . Pathobiologic characteristics of hereditary breast cancer. Hum Pathol 1998; 29: 1140\u20131144.", "DOI": "10.1016/S0046-8177(98)90427-0", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref008", "unstructured": "Verhoog LC , Brekelmans CT , Seynaeve C , et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998; 351: 1316\u20131321."}, {"key": "S1470903105002890_ref019", "unstructured": "Rebbeck TR , Lynch HT , Neuhausen SL , et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. New Engl J Med 2002; 346: 1616\u20131622.", "DOI": "10.1056/NEJMoa012158", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref022", "unstructured": "Pierce LJ , Levin AM , Rebbeck T , et al. Ten-year outcomes of breast-conserving surgery (BCS) and radiotherapy (RT) in women with breast cancer (BC) and germline BRCA1/2 mutations: results of a multi-institutional collaboration. Breast Cancer Res Treat 2003; 82: S7."}, {"key": "S1470903105002890_ref021", "unstructured": "Narod SA , Brunet JS , Ghadirian P , et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 2000; 356: 1876\u20131881.", "DOI": "10.1016/S0140-6736(00)03258-X", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref016", "unstructured": "Agnarsson BA , Jonasson JG , Bjornsdottir IB , et al. Inherited BRCA2 mutation associated with high-grade breast cancer. Breast Cancer Res Treat 1998; 47: 121\u2013127.", "DOI": "10.1023/A:1005853022804", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref015", "unstructured": "Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998; 351: 1451\u20131467.", "DOI": "10.1016/S0140-6736(97)11423-4", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref004", "unstructured": "Cuzick J , Forbes J , Edwards R , Baum M , et al. IBIS investigators. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomized prevention trial. Lancet 2002; 360: 817\u2013824.", "DOI": "10.1016/S0140-6736(02)09962-2", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref024", "unstructured": "Duffy SW , Nixon RM . Estimates of the likely prophylactic effect of tamoxifen in women with high-risk BRCA1 and BRCA2 mutations. Br J Cancer 2002; 86: 218\u2013221.", "DOI": "10.1038/sj.bjc.6600064", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref018", "unstructured": "Rebbeck TR , Levin AM , Eisen A , et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999; 91: 1475\u20131479.", "DOI": "10.1093/jnci/91.17.1475", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref009", "unstructured": "Robson M , Gilewski T , Haas B , et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998; 16: 1642\u20131649.", "DOI": "10.1200/JCO.1998.16.5.1642", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref012", "unstructured": "Karp SE , Tonin PN , Begin LR , et al. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer 1997; 80: 435\u2013441.", "DOI": "10.1002/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref017", "unstructured": "Vaziri SA , Krumroy LM , Elson P , et al. Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis. Clin Cancer Res 2001; 7: 1937\u20131945."}, {"key": "S1470903105002890_ref002", "unstructured": "Powles T , Eeles R , Ashley S , et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial. Lancet 1998; 352: 98\u2013101.", "DOI": "10.1016/S0140-6736(98)85012-5", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref005", "unstructured": "Brose MS , Rebbeck TR , Calzone KA , Stopfer JE , Nathanson KL , Weber BL . Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002; 94: 1365\u20131372.", "DOI": "10.1093/jnci/94.18.1365", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref007", "unstructured": "Metcalfe K , Lynch HT , Ghadirian P , et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004; 22: 2328\u20132335.", "DOI": "10.1200/JCO.2004.04.033", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref003", "unstructured": "Veronesi U , Maisonneuve P , Costa A , et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomized trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 1998; 352: 93\u201397.", "DOI": "10.1016/S0140-6736(98)85011-3", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref001", "unstructured": "Fisher B , Costantino JP , Wickerham DL , et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90: 1371\u20131388.", "DOI": "10.1093/jnci/90.18.1371", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref010", "unstructured": "Phillips KA , Nichol K , Ozcelik H , et al. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. J Natl Cancer Inst 1999; 91: 469\u2013473.", "DOI": "10.1093/jnci/91.5.469", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref013", "unstructured": "Loman N , Johannsson O , Bendahl PO , Borg \u00c5 , Ferno M , Olsson H . Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 1998; 83: 310\u2013319.", "DOI": "10.1002/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref023", "unstructured": "King MC , Wieand S , Hale K , et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001; 286: 2251\u20132256.", "DOI": "10.1001/jama.286.18.2251", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref025", "unstructured": "Schrag D , Kuntz KM , Garber JE , Weeks JC . Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 2000; 283: 617\u2013624.", "DOI": "10.1001/jama.283.5.617", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref026", "unstructured": "Grann VR , Jacobson JS , Thomason D , Hershman D , Heitjan DF , Neugut AI . Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. J Clin Oncol 2002; 20: 2520\u20132529.", "DOI": "10.1200/JCO.2002.10.101", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref011", "unstructured": "Quenneville LA , Phillips KA , Ozcelik H , et al. HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Cancer 2002; 95: 2068\u20132075.", "DOI": "10.1002/cncr.10949", "doi-asserted-by": "crossref"}, {"key": "S1470903105002890_ref006", "unstructured": "Thompson D , Easton DF . Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358\u20131365.", "DOI": "10.1093/jnci/94.18.1358", "doi-asserted-by": "crossref"}], "container-title": ["Breast Cancer Online"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1470903105002890", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 4]], "date-time": "2019-04-04T12:55:38Z", "timestamp": 1554382538000}, "score": 40.43431, "issued": {"date-parts": [[2005, 9]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[2005, 9]]}, "issue": "9"}, "alternative-id": ["S1470903105002890"], "URL": "http://dx.doi.org/10.1017/s1470903105002890", "relation": {"cites": []}, "ISSN": ["1470-9031"], "issn-type": [{"value": "1470-9031", "type": "electronic"}], "subject": ["Cancer Research", "Oncology(nursing)", "Oncology"], "article-number": "e47"}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T16:21:01Z", "timestamp": 1575044461824}, "reference-count": 34, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 7145, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int. J. Cancer"], "published-print": {"date-parts": [[1996, 2, 8]]}, "DOI": "10.1002/(sici)1097-0215(19960208)65:4<446::aid-ijc9>3.0.co;2-x", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T20:04:19Z", "timestamp": 1030305859000}, "page": "446-449", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Male breast cancer in Iceland"], "prefix": "10.1002", "volume": "65", "author": [{"given": "Jon G.", "family": "Jonasson", "sequence": "first", "affiliation": []}, {"given": "Bjarni A.", "family": "Agnarsson", "sequence": "additional", "affiliation": []}, {"given": "Steinunn", "family": "Thorlacius", "sequence": "additional", "affiliation": []}, {"given": "Jorunn E.", "family": "Eyfjord", "sequence": "additional", "affiliation": []}, {"given": "Hrafn", "family": "Tulinius", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB1", "author": "Adami", "volume": "64", "first-page": "1177", "year": "1989", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19890915)64:6<1177::AID-CNCR2820640602>3.0.CO;2-F", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB2", "author": "Aghadiuno", "volume": "16", "first-page": "15", "year": "1987", "journal-title": "Afr. J. med. Sci."}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB3", "author": "Berg", "volume": "75", "first-page": "257", "year": "1995", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19950101)75:1+<257::AID-CNCR2820751311>3.0.CO;2-Y", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB4", "author": "Bezwoda", "volume": "60", "first-page": "1337", "year": "1987", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19870915)60:6<1337::AID-CNCR2820600629>3.0.CO;2-C", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB5", "author": "Bhagwandeen", "volume": "49", "first-page": "89", "year": "1972", "journal-title": "East Afr. med. J."}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB6", "author": "Crichlow", "volume": "70", "first-page": "1165", "year": "1990", "journal-title": "Surg. Clin. N. Amer.", "DOI": "10.1016/S0039-6109(16)45237-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB7", "author": "Donegan", "volume": "41", "first-page": "339", "year": "1991", "journal-title": "CA: Cancer J. Clin."}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB8", "author": "Ekbom", "volume": "5", "first-page": "510", "year": "1994", "journal-title": "Cancer Causes Contr.", "DOI": "10.1007/BF01831378", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB9", "author": "El-Gazayerli", "volume": "17", "first-page": "566", "year": "1963", "journal-title": "Brit. J. Surg."}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB10", "author": "Elston", "first-page": "300", "year": "1987", "unstructured": "Grading of invasive carcinoma of the breast. In: and (eds.), Diagnostic histopathology of the breast, pp. 300\u2013311, Churchill Livingstone, New York (1987).", "volume-title": "Diagnostic histopathology of the breast"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB11", "author": "Engin", "volume": "53", "first-page": "128", "year": "1993", "journal-title": "J. surg. Oncol.", "DOI": "10.1002/jso.2930530216", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB12", "author": "Erlichman", "volume": "2", "first-page": "903", "year": "1984", "journal-title": "J. clin. Oncol.", "DOI": "10.1200/JCO.1984.2.8.903", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB13", "author": "Ewertz", "volume": "43", "first-page": "27", "year": "1989", "journal-title": "Int. J. Cancer", "DOI": "10.1002/ijc.2910430107", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB14", "author": "Gattuso", "volume": "70", "first-page": "777", "year": "1992", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19920815)70:4<777::AID-CNCR2820700410>3.0.CO;2-Z", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB15", "author": "Gudlaugsdottir", "unstructured": ", , , , , and , DNA flow cytometric analysis increases the accuracy of prognostic evaluation in breast cancer. (in press)."}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB16", "author": "Hatschek", "volume": "33", "first-page": "609", "year": "1994", "journal-title": "Acta oncol.", "DOI": "10.3109/02841869409121770", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB17", "author": "Hecht", "volume": "102", "first-page": "s25", "year": "1994", "journal-title": "Amer. J. clin. Pathol."}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB18", "author": "Hedley", "volume": "31", "first-page": "1333", "year": "1983", "journal-title": "J. Histochem. Cytochem.", "DOI": "10.1177/31.11.6619538", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB19", "author": "Heller", "volume": "188", "first-page": "60", "year": "1978", "journal-title": "Ann. Surg.", "DOI": "10.1097/00000658-197807000-00010", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB20", "author": "Hultborn", "volume": "26", "first-page": "241", "year": "1987", "journal-title": "Acta oncol.", "DOI": "10.3109/02841868709089970", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB21", "author": "Jonasson", "volume": "425", "first-page": "349", "year": "1994", "journal-title": "Virchows Arch.", "DOI": "10.1007/BF00189572", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB22", "author": "La Vecchia", "volume": "51", "first-page": "62", "year": "1992", "journal-title": "Int. J. Cancer", "DOI": "10.1002/ijc.2910510113", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB23", "author": "Merkel", "volume": "72", "first-page": "1926", "year": "1993", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19930915)72:6<1926::AID-CNCR2820720622>3.0.CO;2-I", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB24", "author": "Nance", "volume": "20", "first-page": "1220", "year": "1989", "journal-title": "Hum. Pathol.", "DOI": "10.1016/S0046-8177(89)80017-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB25", "author": "Ouriel", "volume": "159", "first-page": "373", "year": "1984", "journal-title": "Surg. Gynecol. Obstet."}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB26", "author": "Simon", "volume": "21", "first-page": "55", "year": "1992", "journal-title": "Breast Cancer Res. Treat.", "DOI": "10.1007/BF01811964", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB27", "author": "Stalsberg", "volume": "4", "first-page": "143", "year": "1993", "journal-title": "Cancer Causes Contr.", "DOI": "10.1007/BF00053155", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB28", "author": "Thorlacius", "volume": "346", "first-page": "544", "year": "1995", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(95)91383-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB29", "author": "Thornthwaite", "volume": "1", "first-page": "229", "year": "1980", "journal-title": "Cytometry", "DOI": "10.1002/cyto.990010309", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB30", "author": "Tulinius", "volume": "96", "first-page": "229", "year": "1988", "journal-title": "Acta pathol. microbiol. immunol. scand.", "DOI": "10.1111/j.1699-0463.1988.tb05296.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB31", "author": "Tulinius", "volume": "29", "first-page": "158", "year": "1992", "journal-title": "J. med. Genet.", "DOI": "10.1136/jmg.29.3.158", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB32", "author": "van Geel", "volume": "72", "first-page": "724", "year": "1985", "journal-title": "Brit. J. Surg.", "DOI": "10.1002/bjs.1800720918", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB33", "author": "Visfeldt", "volume": "32", "first-page": "985", "year": "1973", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(197310)32:4<985::AID-CNCR2820320433>3.0.CO;2-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X-BIB34", "author": "World Health Organisation", "year": "1981", "unstructured": "World Health Organisation, International histological classification of tumours. No. 2. Histological typing of breast tumours, 2nd ed. WHO, Geneva (1981).", "volume-title": "International histological classification of tumours. No. 2. Histological typing of breast tumours"}], "container-title": ["International Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0215(19960208)65:4%3C446::AID-IJC9%3E3.0.CO;2-X", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0215(19960208)65:4%3C446::AID-IJC9%3E3.0.CO;2-X", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T02:24:24Z", "timestamp": 1533176664000}, "score": 39.643806, "issued": {"date-parts": [[1996, 2, 8]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[1996, 2, 8]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/(sici)1097-0215(19960208)65:4<446::aid-ijc9>3.0.co;2-x", "relation": {"cites": []}, "ISSN": ["0020-7136", "1097-0215"], "issn-type": [{"value": "0020-7136", "type": "print"}, {"value": "1097-0215", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:43:41Z", "timestamp": 1574135021225}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "S1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2000, 3, 1]], "date-time": "2000-03-01T00:00:00Z", "timestamp": 951868800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res"], "published-print": {"date-parts": [[2000, 3]]}, "DOI": "10.1186/bcr100", "type": "journal-article", "created": {"date-parts": [[2002, 9, 26]], "date-time": "2002-09-26T12:07:27Z", "timestamp": 1033042047000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Constitutional alterations of 9p23-24 in independent BRCA2 breast cancer families"], "prefix": "10.1186", "volume": "2", "author": [{"given": "M", "family": "Schwab", "sequence": "first", "affiliation": []}, {"given": "L", "family": "Savelyeva", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Claas", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "An", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Brouwers", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2000, 3, 12]]}, "container-title": ["Breast Cancer Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/bcr100.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/bcr100/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr100.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 1, 18]], "date-time": "2017-01-18T11:34:33Z", "timestamp": 1484739273000}, "score": 38.391983, "issued": {"date-parts": [[2000, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 3]]}, "issue": "S1"}, "alternative-id": ["100"], "URL": "http://dx.doi.org/10.1186/bcr100", "ISSN": ["1465-542X"], "issn-type": [{"value": "1465-542X", "type": "electronic"}], "article-number": "P1.13"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T07:05:09Z", "timestamp": 1575097509094}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "8974", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 8, 1]], "date-time": "1995-08-01T00:00:00Z", "timestamp": 807235200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet"], "published-print": {"date-parts": [[1995, 8]]}, "DOI": "10.1016/s0140-6736(95)91383-1", "type": "journal-article", "created": {"date-parts": [[2003, 10, 11]], "date-time": "2003-10-11T10:14:31Z", "timestamp": 1065867271000}, "page": "544-545", "source": "Crossref", "is-referenced-by-count": 65, "title": ["Linkage to BRCA2 region in hereditary male breast cancer"], "prefix": "10.1016", "volume": "346", "author": [{"given": "S.", "family": "Thorlacius", "sequence": "first", "affiliation": []}, {"given": "H.M.", "family": "Ogmundsdottir", "sequence": "additional", "affiliation": []}, {"given": "J.E.", "family": "Eyfjord", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Tryggvadottir", "sequence": "additional", "affiliation": []}, {"given": "G.H.", "family": "Olafsdottir", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Tulinius", "sequence": "additional", "affiliation": []}, {"given": "J.G.", "family": "Jonasson", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0140673695913831?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0140673695913831?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T20:40:07Z", "timestamp": 1555360807000}, "score": 37.62828, "issued": {"date-parts": [[1995, 8]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[1995, 8]]}, "issue": "8974"}, "alternative-id": ["S0140673695913831"], "URL": "http://dx.doi.org/10.1016/s0140-6736(95)91383-1", "ISSN": ["0140-6736"], "issn-type": [{"value": "0140-6736", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:13:52Z", "timestamp": 1574115232279}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "DOI": "10.1054/bjoc.2000.1627", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T11:30:18Z", "timestamp": 1027683018000}, "page": "482-488", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons"], "prefix": "10.1038", "volume": "84", "author": [{"given": "S", "family": "Pages", "sequence": "first", "affiliation": []}, {"given": "V", "family": "Caux", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Stoppa-Lyonnet", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Tosi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2001, 2, 15]]}, "container-title": ["British Journal of Cancer"], "deposited": {"date-parts": [[2011, 6, 3]], "date-time": "2011-06-03T15:38:26Z", "timestamp": 1307115506000}, "score": 37.107185, "issued": {"date-parts": [[2001]]}, "references-count": 0, "journal-issue": {"issue": "4"}, "alternative-id": ["6691627"], "URL": "http://dx.doi.org/10.1054/bjoc.2000.1627", "ISSN": ["1532-1827"], "issn-type": [{"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T08:36:47Z", "timestamp": 1575448607241}, "reference-count": 0, "publisher": "Spandidos Publications", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncol Rep"], "DOI": "10.3892/or.6.6.1435", "type": "journal-article", "created": {"date-parts": [[2014, 3, 10]], "date-time": "2014-03-10T07:43:34Z", "timestamp": 1394437414000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families."], "prefix": "10.3892", "author": [{"given": "J", "family": "Papp", "sequence": "first", "affiliation": []}, {"given": "L", "family": "Raicevic", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Milasin", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "Dimitrijevic", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Radulovic", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Olah", "sequence": "additional", "affiliation": []}], "member": "2249", "published-online": {"date-parts": [[1999, 11, 1]]}, "container-title": ["Oncology Reports"], "link": [{"URL": "https://spandidos-publications.com/10.3892/or.6.6.1435/download", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T09:27:20Z", "timestamp": 1493285240000}, "score": 35.712883, "issued": {"date-parts": [[1999, 11, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3892/or.6.6.1435", "ISSN": ["1021-335X", "1791-2431"], "issn-type": [{"value": "1021-335X", "type": "print"}, {"value": "1791-2431", "type": "electronic"}], "subject": ["Cancer Research", "Oncology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:23:10Z", "timestamp": 1574144590473}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "23", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 12, 4]]}, "DOI": "10.1093/jnci/94.23.1773", "type": "journal-article", "created": {"date-parts": [[2002, 12, 3]], "date-time": "2002-12-03T21:23:16Z", "timestamp": 1038950596000}, "page": "1773-1779", "source": "Crossref", "is-referenced-by-count": 238, "title": ["Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers"], "prefix": "10.1093", "volume": "94", "author": [{"given": "S. A.", "family": "Narod", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["CancerSpectrum Knowledge Environment"], "link": [{"URL": "http://academic.oup.com/jnci/article-pdf/94/23/1773/9849275/1773.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T11:16:11Z", "timestamp": 1503573371000}, "score": 35.478874, "issued": {"date-parts": [[2002, 12, 4]]}, "references-count": 0, "journal-issue": {"issue": "23"}, "URL": "http://dx.doi.org/10.1093/jnci/94.23.1773", "ISSN": ["1460-2105"], "issn-type": [{"value": "1460-2105", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T10:58:24Z", "timestamp": 1574333904786}, "reference-count": 25, "publisher": "Oxford University Press (OUP)", "issue": "23", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JNCI Journal of the National Cancer Institute"], "published-print": {"date-parts": [[2007, 12, 5]]}, "DOI": "10.1093/jnci/djm203", "type": "journal-article", "created": {"date-parts": [[2007, 11, 28]], "date-time": "2007-11-28T02:09:48Z", "timestamp": 1196215788000}, "page": "1811-1814", "source": "Crossref", "is-referenced-by-count": 165, "title": ["Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers"], "prefix": "10.1093", "volume": "99", "author": [{"given": "Y. C.", "family": "Tai", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Domchek", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Parmigiani", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Chen", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2007, 11, 27]]}, "reference": [{"issue": "1", "key": "1_10782877", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.3322/canjclin.49.1.8", "volume": "49", "author": "Landis", "year": "1999", "journal-title": "CA: A Cancer Journal for Clinicians", "ISSN": "http://id.crossref.org/issn/0007-9235", "issn-type": "print"}, {"issue": "5", "key": "2_10942277", "doi-asserted-by": "publisher", "first-page": "744", "DOI": "10.1002/(SICI)1097-0142(19990901)86:5<744::AID-CNCR4>3.0.CO;2-G", "volume": "86", "author": "Lynch", "year": "1999", "journal-title": "Cancer", "ISSN": "http://id.crossref.org/issn/0008-543X", "issn-type": "print"}, {"issue": "8974", "key": "3_15992072", "doi-asserted-by": "publisher", "first-page": "544", "DOI": "10.1016/S0140-6736(95)91383-1", "volume": "346", "author": "Thorlacius", "year": "1995", "journal-title": "Lancet", "ISSN": "http://id.crossref.org/issn/0140-6736", "issn-type": "print"}, {"issue": "6559", "key": "4_16122840", "doi-asserted-by": "publisher", "first-page": "789", "DOI": "10.1038/378789a0", "volume": "378", "author": "Wooster", "year": "1995", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "3", "key": "5_5921103", "doi-asserted-by": "publisher", "first-page": "676", "DOI": "10.1086/301749", "volume": "62", "author": "Ford", "year": "1998", "journal-title": "American journal of human genetics", "ISSN": "http://id.crossref.org/issn/0002-9297", "issn-type": "print"}, {"issue": "1", "key": "6_16247285", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1038/ng0596-123", "volume": "13", "author": "Couch", "year": "1996", "journal-title": "Nature genetics", "ISSN": "http://id.crossref.org/issn/1061-4036", "issn-type": "print"}, {"issue": "1", "key": "7_16866124", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1086/513891", "volume": "61", "author": "Easton", "year": "1997", "journal-title": "American journal of human genetics", "ISSN": "http://id.crossref.org/issn/0002-9297", "issn-type": "print"}, {"issue": "2", "key": "8_11030592", "doi-asserted-by": "publisher", "first-page": "410", "DOI": "10.1086/318181", "volume": "68", "author": "Thompson", "year": "2001", "journal-title": "American journal of human genetics", "ISSN": "http://id.crossref.org/issn/0002-9297", "issn-type": "print"}, {"issue": "23", "key": "9_23006999", "doi-asserted-by": "publisher", "first-page": "1694", "DOI": "10.1093/jnci/djj465", "volume": "98", "author": "Risch", "year": "2006", "journal-title": "JNCI Journal of the National Cancer Institute", "ISSN": "http://id.crossref.org/issn/0027-8874", "issn-type": "print"}, {"issue": "1", "key": "10_15594579", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1038/ng0594-103", "volume": "7", "author": "Stratton", "year": "1994", "journal-title": "Nature genetics", "ISSN": "http://id.crossref.org/issn/1061-4036", "issn-type": "print"}, {"issue": "6", "key": "11_6383959", "doi-asserted-by": "publisher", "first-page": "1800", "DOI": "10.1086/302678", "volume": "65", "author": "Struewing", "year": "1999", "journal-title": "American journal of human genetics", "ISSN": "http://id.crossref.org/issn/0002-9297", "issn-type": "print"}, {"issue": "3", "key": "12_10594832", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1089/10906570050501579", "volume": "4", "author": "Sverdlov", "year": "2000", "journal-title": "Genetic testing", "ISSN": "http://id.crossref.org/issn/1090-6576", "issn-type": "print"}, {"issue": "2", "key": "13_16678084", "first-page": "313", "volume": "60", "author": "Friedman", "year": "1997", "journal-title": "American journal of human genetics", "ISSN": "http://id.crossref.org/issn/0002-9297", "issn-type": "print"}, {"issue": "5", "key": "14_10744310", "first-page": "995", "volume": "59", "author": "Csokay", "year": "1999", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "6", "key": "15_16959377", "doi-asserted-by": "publisher", "first-page": "1480", "DOI": "10.1200/JCO.20.6.1480", "volume": "20", "author": "Frank", "year": "2002", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "18", "key": "16_17244330", "doi-asserted-by": "publisher", "first-page": "1365", "DOI": "10.1093/jnci/94.18.1365", "volume": "94", "author": "Brose", "year": "2002", "journal-title": "JNCI Journal of the National Cancer Institute", "ISSN": "http://id.crossref.org/issn/0027-8874", "issn-type": "print"}, {"issue": "6", "key": "17_21601106", "doi-asserted-by": "publisher", "first-page": "863", "DOI": "10.1200/JCO.2005.03.6772", "volume": "24", "author": "Chen", "year": "2006", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "11", "key": "18_17633974", "doi-asserted-by": "publisher", "first-page": "1837", "DOI": "10.1002/sim.1428", "volume": "22", "author": "Fay", "year": "2003", "journal-title": "Statistics in medicine", "ISSN": "http://id.crossref.org/issn/0277-6715", "issn-type": "print"}, {"issue": "3", "key": "19_6506156", "doi-asserted-by": "publisher", "first-page": "1119", "DOI": "10.1086/302808", "volume": "66", "author": "Kraft", "year": "2000", "journal-title": "American journal of human genetics", "ISSN": "http://id.crossref.org/issn/0002-9297", "issn-type": "print"}, {"issue": "1", "key": "20_5868667", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1086/301670", "volume": "62", "author": "Parmigiani", "year": "1998", "journal-title": "American journal of human genetics", "ISSN": "http://id.crossref.org/issn/0002-9297", "issn-type": "print"}, {"issue": "11", "key": "22_28005037", "doi-asserted-by": "publisher", "first-page": "1329", "DOI": "10.1200/JCO.2006.09.1066", "volume": "25", "author": "Chen", "year": "2007", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "4", "key": "23_16315393", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.3109/02841869609109913", "volume": "35", "author": "Andersen", "year": "1996", "journal-title": "Acta oncologica (Stockholm, Sweden)", "ISSN": "http://id.crossref.org/issn/0284-186X", "issn-type": "print"}, {"issue": "1", "key": "24_16925150", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1038/sj.bjc.6600008", "volume": "86", "author": "Antoniou", "year": "2002", "journal-title": "British Journal of Cancer", "ISSN": "http://id.crossref.org/issn/1532-1827", "issn-type": "print"}, {"issue": "4", "key": "25_10144530", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1002/ijc.2910530403", "volume": "53", "author": "Sasco", "year": "1993", "journal-title": "International journal of cancer. Journal international du cancer", "ISSN": "http://id.crossref.org/issn/0020-7136", "issn-type": "print"}, {"issue": "11", "key": "26_17085712", "doi-asserted-by": "publisher", "first-page": "844", "DOI": "10.1093/jnci/94.11.844", "volume": "94", "author": "Euhus", "year": "2002", "journal-title": "JNCI Journal of the National Cancer Institute", "ISSN": "http://id.crossref.org/issn/0027-8874", "issn-type": "print"}], "container-title": ["JNCI Journal of the National Cancer Institute"], "language": "en", "link": [{"URL": "http://academic.oup.com/jnci/article-pdf/99/23/1811/7688930/djm203.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T13:49:10Z", "timestamp": 1503496150000}, "score": 34.54062, "issued": {"date-parts": [[2007, 11, 27]]}, "references-count": 25, "journal-issue": {"published-online": {"date-parts": [[2007, 12, 4]]}, "published-print": {"date-parts": [[2007, 12, 5]]}, "issue": "23"}, "URL": "http://dx.doi.org/10.1093/jnci/djm203", "relation": {"cites": []}, "ISSN": ["0027-8874", "1460-2105"], "issn-type": [{"value": "0027-8874", "type": "print"}, {"value": "1460-2105", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:42:25Z", "timestamp": 1574476945291}, "reference-count": 9, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 1, 1]], "date-time": "2012-01-01T00:00:00Z", "timestamp": 1325376000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Diseases: A Year Book Quarterly"], "published-print": {"date-parts": [[2012, 1]]}, "DOI": "10.1016/j.breastdis.2012.03.011", "type": "journal-article", "created": {"date-parts": [[2012, 5, 18]], "date-time": "2012-05-18T05:46:37Z", "timestamp": 1337319997000}, "page": "140-141", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers"], "prefix": "10.1016", "volume": "23", "author": [{"given": "S.", "family": "Abouharb", "sequence": "first", "affiliation": []}, {"given": "J.K.", "family": "Litton", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Breast Diseases: A Year Book Quarterly"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1043321X1200094X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1043321X1200094X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 23]], "date-time": "2018-11-23T10:50:14Z", "timestamp": 1542970214000}, "score": 34.151768, "issued": {"date-parts": [[2012, 1]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2012, 1]]}, "issue": "2"}, "alternative-id": ["S1043321X1200094X"], "URL": "http://dx.doi.org/10.1016/j.breastdis.2012.03.011", "ISSN": ["1043-321X"], "issn-type": [{"value": "1043-321X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T00:00:47Z", "timestamp": 1576800047617}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2011, 5, 20]]}, "DOI": "10.1200/jco.2011.29.15_suppl.1516", "type": "journal-article", "created": {"date-parts": [[2017, 2, 23]], "date-time": "2017-02-23T18:58:03Z", "timestamp": 1487876283000}, "page": "1516-1516", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Prospective study of breast cancer risk in mutation-negative women from BRCA1 or BRCA2 mutation-positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)."], "prefix": "10.1200", "volume": "29", "author": [{"given": "S.", "family": "Harvey", "sequence": "first", "affiliation": []}, {"given": "R. L.", "family": "Milne", "sequence": "additional", "affiliation": []}, {"given": "K. E.", "family": "Birch", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Weideman", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "McLachlan", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Friedlander", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Goldgar", "sequence": "additional", "affiliation": []}, {"given": "J. L.", "family": "Hopper", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Phillips", "sequence": "additional", "affiliation": []}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2011.29.15_suppl.1516", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:25:00Z", "timestamp": 1574893500000}, "score": 33.760582, "issued": {"date-parts": [[2011, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2011, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/jco.2011.29.15_suppl.1516"], "URL": "http://dx.doi.org/10.1200/jco.2011.29.15_suppl.1516", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:54:53Z", "timestamp": 1574312093875}, "reference-count": 36, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2009, 7, 17]], "date-time": "2009-07-17T00:00:00Z", "timestamp": 1247788800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2009, 12]]}, "DOI": "10.1007/s10549-009-0475-1", "type": "journal-article", "created": {"date-parts": [[2009, 7, 16]], "date-time": "2009-07-16T04:59:58Z", "timestamp": 1247720398000}, "page": "539-546", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence"], "prefix": "10.1007", "volume": "118", "author": [{"given": "P.", "family": "Shah", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Rosen", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Stopfer", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Siegfried", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Kaltman", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Mason", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Armstrong", "sequence": "additional", "affiliation": []}, {"given": "K. L.", "family": "Nathanson", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Schnall", "sequence": "additional", "affiliation": []}, {"given": "S. M.", "family": "Domchek", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 7, 17]]}, "reference": [{"issue": "5", "key": "475_CR1", "doi-asserted-by": "crossref", "first-page": "1117", "DOI": "10.1086/375033", "volume": "72", "author": "A Antoniou", "year": "2003", "unstructured": "Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130", "journal-title": "Am J Hum Genet"}, {"issue": "5645", "key": "475_CR2", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1126/science.1088759", "volume": "302", "author": "MC King", "year": "2003", "unstructured": "King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646", "journal-title": "Science"}, {"issue": "19", "key": "475_CR3", "doi-asserted-by": "crossref", "first-page": "3360", "DOI": "10.1200/JCO.2000.18.19.3360", "volume": "18", "author": "LJ Pierce", "year": "2000", "unstructured": "Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A, Dawson L et al (2000) Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18(19):3360\u20133369", "journal-title": "J Clin Oncol"}, {"issue": "43", "key": "475_CR4", "doi-asserted-by": "crossref", "first-page": "5825", "DOI": "10.1038/sj.onc.1209881", "volume": "25", "author": "SM Domchek", "year": "2006", "unstructured": "Domchek SM, Weber BL (2006) Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene 25(43):5825\u20135831", "journal-title": "Oncogene"}, {"issue": "2", "key": "475_CR5", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1056/NEJMcp071286", "volume": "357", "author": "M Robson", "year": "2007", "unstructured": "Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer [see comment]. N Engl J Med 357(2):154\u2013162", "journal-title": "N Engl J Med"}, {"issue": "21", "key": "475_CR6", "doi-asserted-by": "crossref", "first-page": "1616", "DOI": "10.1056/NEJMoa012158", "volume": "346", "author": "TR Rebbeck", "year": "2002", "unstructured": "Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t Veer L, Garber JE et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616\u20131622", "journal-title": "N Engl J Med"}, {"issue": "21", "key": "475_CR7", "doi-asserted-by": "crossref", "first-page": "1609", "DOI": "10.1056/NEJMoa020119", "volume": "346", "author": "ND Kauff", "year": "2002", "unstructured": "Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609\u20131615", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "475_CR8", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1001/jama.296.2.185", "volume": "296", "author": "A Finch", "year": "2006", "unstructured": "Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B et al (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 296(2):185\u2013192", "journal-title": "JAMA"}, {"issue": "30", "key": "475_CR9", "doi-asserted-by": "crossref", "first-page": "7491", "DOI": "10.1200/JCO.2004.00.7138", "volume": "23", "author": "A Eisen", "year": "2005", "unstructured": "Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K et al (2005) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 23(30):7491\u20137496", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "475_CR10", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1093/jnci/djn442", "volume": "101", "author": "TR Rebbeck", "year": "2009", "unstructured": "Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387", "journal-title": "J Natl Cancer Inst"}, {"issue": "3", "key": "475_CR11", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/S1470-2045(06)70585-X", "volume": "7", "author": "SM Domchek", "year": "2006", "unstructured": "Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223\u2013229", "journal-title": "Lancet Oncol"}, {"issue": "14", "key": "475_CR12", "doi-asserted-by": "crossref", "first-page": "5175", "DOI": "10.1158/1078-0432.CCR-04-2424", "volume": "11", "author": "SR Lakhani", "year": "2005", "unstructured": "Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11(14):5175\u20135180", "journal-title": "Clin Cancer Res"}, {"issue": "34", "key": "475_CR13", "doi-asserted-by": "crossref", "first-page": "8629", "DOI": "10.1200/JCO.2005.02.9199", "volume": "23", "author": "JL Kramer", "year": "2005", "unstructured": "Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH (2005) Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 23(34):8629\u20138635", "journal-title": "J Clin Oncol"}, {"issue": "8", "key": "475_CR14", "doi-asserted-by": "crossref", "first-page": "1331", "DOI": "10.1200/JCO.2007.13.9626", "volume": "26", "author": "ND Kauff", "year": "2008", "unstructured": "Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE et al (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331\u20131337", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "475_CR15", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.7326/0003-4819-148-9-200805060-00007", "volume": "148", "author": "E Warner", "year": "2008", "unstructured": "Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148(9):671\u2013679", "journal-title": "Ann Intern Med"}, {"issue": "2", "key": "475_CR16", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.3322/canjclin.57.2.75", "volume": "57", "author": "D Saslow", "year": "2007", "unstructured": "Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD et al (2007) American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75\u201389", "journal-title": "CA Cancer J Clin"}, {"issue": "1", "key": "475_CR17", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1148/radiology.215.1.r00ap01267", "volume": "215", "author": "CK Kuhl", "year": "2000", "unstructured": "Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A et al (2000) Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215(1):267\u2013279", "journal-title": "Radiology"}, {"issue": "9473", "key": "475_CR18", "doi-asserted-by": "crossref", "first-page": "1769", "DOI": "10.1016/S0140-6736(05)66481-1", "volume": "365", "author": "MO Leach", "year": "2005", "unstructured": "Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365(9473):1769\u20131778", "journal-title": "Lancet"}, {"issue": "11", "key": "475_CR19", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.1001/jama.292.11.1317", "volume": "292", "author": "E Warner", "year": "2004", "unstructured": "Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317\u20131325", "journal-title": "JAMA"}, {"issue": "2", "key": "475_CR20", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1148/radiol.2442060461", "volume": "244", "author": "CD Lehman", "year": "2007", "unstructured": "Lehman CD, Isaacs C, Schnall MD, Pisano ED, Ascher SM, Weatherall PT et al (2007) Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 244(2):381\u2013388", "journal-title": "Radiology"}, {"issue": "5", "key": "475_CR21", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1056/NEJMoa031759", "volume": "351", "author": "M Kriege", "year": "2004", "unstructured": "Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427\u2013437", "journal-title": "N Engl J Med"}, {"issue": "9", "key": "475_CR22", "doi-asserted-by": "crossref", "first-page": "1784", "DOI": "10.1002/cncr.22603", "volume": "109", "author": "F Laki", "year": "2007", "unstructured": "Laki F, Kirova YM, This P, Plancher C, Asselain B, Sastre X, Stoppa-Lyonnet D, Salmon R, for the IC-BOCRSG IC-BOCRSG: Institut Curie -Breast Ovary Cancer Risk Study Group (2007) Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation. Cancer 109(9):1784\u20131790", "journal-title": "Cancer"}, {"issue": "12", "key": "475_CR23", "doi-asserted-by": "crossref", "first-page": "2328", "DOI": "10.1200/JCO.2004.04.033", "volume": "22", "author": "K Metcalfe", "year": "2004", "unstructured": "Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328\u20132335", "journal-title": "J Clin Oncol"}, {"issue": "17", "key": "475_CR24", "doi-asserted-by": "crossref", "first-page": "1475", "DOI": "10.1093/jnci/91.17.1475", "volume": "91", "author": "TR Rebbeck", "year": "1999", "unstructured": "Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L et al (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91(17):1475\u20131479", "journal-title": "J Natl Cancer Inst"}, {"issue": "13", "key": "475_CR25", "doi-asserted-by": "crossref", "first-page": "941", "DOI": "10.1093/jnci/95.13.941", "volume": "95", "author": "HM Klaren", "year": "2003", "unstructured": "Klaren HM, van\u2019t Veer LJ, van Leeuwen FE, Rookus MA (2003) Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation [see comment]. J Natl Cancer Inst 95(13):941\u2013947", "journal-title": "J Natl Cancer Inst"}, {"issue": "18", "key": "475_CR26", "doi-asserted-by": "crossref", "first-page": "2251", "DOI": "10.1001/jama.286.18.2251", "volume": "286", "author": "MC King", "year": "2001", "unstructured": "King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National surgical adjuvant breast and bowel project (NSABP-P1) breast cancer prevention trial. JAMA 286(18):2251\u20132256", "journal-title": "JAMA"}, {"issue": "9245", "key": "475_CR27", "doi-asserted-by": "crossref", "first-page": "1876", "DOI": "10.1016/S0140-6736(00)03258-X", "volume": "356", "author": "SA Narod", "year": "2000", "unstructured": "Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary breast cancer clinical study group. Lancet 356(9245):1876\u20131881", "journal-title": "Lancet"}, {"issue": "9", "key": "475_CR28", "doi-asserted-by": "crossref", "first-page": "2281", "DOI": "10.1002/ijc.21536", "volume": "118", "author": "J Gronwald", "year": "2006", "unstructured": "Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M et al (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118(9):2281\u20132284", "journal-title": "Int J Cancer"}, {"issue": "6", "key": "475_CR29", "doi-asserted-by": "crossref", "first-page": "2029", "DOI": "10.1158/1078-0432.CCR-03-1061", "volume": "10", "author": "WD Foulkes", "year": "2004", "unstructured": "Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P et al (2004) Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 10(6):2029\u20132034", "journal-title": "Clin Cancer Res"}, {"issue": "9", "key": "475_CR30", "doi-asserted-by": "crossref", "first-page": "2310", "DOI": "10.1200/JCO.2002.09.023", "volume": "20", "author": "SR Lakhani", "year": "2002", "unstructured": "Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310\u20132318", "journal-title": "J Clin Oncol"}, {"issue": "22", "key": "475_CR31", "first-page": "4987", "volume": "57", "author": "RB Clarke", "year": "1997", "unstructured": "Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57(22):4987\u20134991", "journal-title": "Cancer Res"}, {"issue": "5", "key": "475_CR32", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1046/j.1432-0436.1998.6250221.x", "volume": "62", "author": "N Zeps", "year": "1998", "unstructured": "Zeps N, Bentel JM, Papadimitriou JM, D\u2019Antuono MF, Dawkins HJ (1998) Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation 62(5):221\u2013226", "journal-title": "Differentiation"}, {"issue": "43", "key": "475_CR33", "doi-asserted-by": "crossref", "first-page": "5885", "DOI": "10.1038/sj.onc.1209871", "volume": "25", "author": "B Evers", "year": "2006", "unstructured": "Evers B, Jonkers J (2006) Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 25(43):5885\u20135897", "journal-title": "Oncogene"}, {"issue": "19", "key": "475_CR34", "doi-asserted-by": "crossref", "first-page": "1482", "DOI": "10.1093/jnci/djg050", "volume": "95", "author": "WD Foulkes", "year": "2003", "unstructured": "Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N et al (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95(19):1482\u20131485", "journal-title": "J Natl Cancer Inst"}, {"issue": "4", "key": "475_CR35", "doi-asserted-by": "crossref", "first-page": "514", "DOI": "10.1016/S0959-8049(99)00337-8", "volume": "36", "author": "MM Tilanus-Linthorst", "year": "2000", "unstructured": "Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, Oudkerk M (2000) Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer 36(4):514\u2013519", "journal-title": "Eur J Cancer"}, {"issue": "20", "key": "475_CR36", "doi-asserted-by": "crossref", "first-page": "2374", "DOI": "10.1001/jama.295.20.2374", "volume": "295", "author": "SK Plevritis", "year": "2006", "unstructured": "Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE et al (2006) Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295(20):2374\u20132384", "journal-title": "JAMA"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10549-009-0475-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s10549-009-0475-1/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-009-0475-1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:32:19Z", "timestamp": 1559233939000}, "score": 33.687782, "issued": {"date-parts": [[2009, 7, 17]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2009, 12]]}, "issue": "3"}, "alternative-id": ["475"], "URL": "http://dx.doi.org/10.1007/s10549-009-0475-1", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:11:16Z", "timestamp": 1574334676928}, "publisher-location": "New York, NY", "reference-count": 109, "publisher": "Springer New York", "isbn-type": [{"value": "9781441906847", "type": "print"}, {"value": "9781441906854", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010]]}, "DOI": "10.1007/978-1-4419-0685-4_12", "type": "book-chapter", "created": {"date-parts": [[2009, 11, 11]], "date-time": "2009-11-11T00:44:50Z", "timestamp": 1257900290000}, "page": "261-276", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Male Breast Cancer"], "prefix": "10.1007", "author": [{"given": "Ian S.", "family": "Fentiman", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 8, 3]]}, "reference": [{"key": "12_CR1", "first-page": "301", "volume": "92", "author": "H Amir", "year": "2000", "unstructured": "Amir H, Kaaya EE, Kwesigabo G, Kiitinya JN (2000) Breast cancer before and after the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996. J Natl Med Assoc 92:301\u2013305", "journal-title": "J Natl Med Assoc"}, {"issue": "3", "key": "12_CR2", "first-page": "191", "volume": "90", "author": "JA Andersen", "year": "1982", "unstructured": "Andersen JA, Gram JB (1982) Male breast at autopsy. Acta Pathol Microbiol Immunol Scand 90(3):191\u2013197", "journal-title": "Acta Pathol Microbiol Immunol Scand"}, {"key": "12_CR3", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1023/B:BREA.0000010701.08825.2d", "volume": "83", "author": "WF Anderson", "year": "2004", "unstructured": "Anderson WF, Althuis MD, Brinton LA et al (2004) Is male breast cancer similar or different from female breast cancer? Br Cancer Res Treat 83:77\u201386", "journal-title": "Br Cancer Res Treat"}, {"key": "12_CR4", "doi-asserted-by": "crossref", "first-page": "1330", "DOI": "10.1093/jnci/94.17.1330", "volume": "94", "author": "A Auvinen", "year": "2002", "unstructured": "Auvinen A, Curtis RE, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94:1330\u20131332", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR5", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1177/030089169007600106", "volume": "76", "author": "P Ballerina", "year": "1990", "unstructured": "Ballerina P, Recchione C, Cavalleri A et al (1990) Hormones in male breast cancer. Tumori 76:26\u201328", "journal-title": "Tumori"}, {"key": "12_CR6", "doi-asserted-by": "crossref", "first-page": "R2", "DOI": "10.1186/bcr419", "volume": "4", "author": "VM Basham", "year": "2002", "unstructured": "Basham VM, Lipscombe JM, Ward JM et al (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Br Cancer Res 4:R2", "journal-title": "Br Cancer Res"}, {"key": "12_CR7", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1016/S0003-3944(02)00816-7", "volume": "127", "author": "Z Benchellal", "year": "2002", "unstructured": "Benchellal Z, Wagner A, Harchaoui Y et al (2002) Male breast cancer: 19 case reports. Ann Chir 127:619", "journal-title": "Ann Chir"}, {"key": "12_CR8", "first-page": "1035", "volume": "76", "author": "L Bernstein", "year": "1986", "unstructured": "Bernstein L, Depue RH, Ross RK et al (1986) Higher maternal levels of free estradiol in first compared with second pregnancy: early gestational differences. J Natl Cancer Inst 76:1035\u20131039", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR9", "first-page": "176", "volume": "49", "author": "S Bhagwandin", "year": "1972", "unstructured": "Bhagwandin S (1972) Carcinoma of the male breast in Zambia. East Afr Med J 49:176\u2013179", "journal-title": "East Afr Med J"}, {"key": "12_CR10", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1056/NEJM199603213341201", "volume": "334", "author": "S Bhatia", "year": "1996", "unstructured": "Bhatia S, Robison LL, Oberlin O et al (1996) Breast cancer and other second neoplasms after childhood Hodgkin\u2019s disease. N Engl J Med 334:745\u2013751", "journal-title": "N Engl J Med"}, {"key": "12_CR11", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1111/j.1600-079X.1999.tb00568.x", "volume": "26", "author": "GC Brainard", "year": "1999", "unstructured": "Brainard GC, Kavet R, Keiferts LI (1999) The relationship between electromagnetic field and light exposures by melatonin and breast cancer risk. J Pineal Res 26:65\u2013100", "journal-title": "J Pineal Res"}, {"key": "12_CR12", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.1016/0022-4731(76)90084-4", "volume": "7", "author": "E Calabresi", "year": "1976", "unstructured": "Calabresi E, De Giull A, Becchiolini A et al (1976) Plasma estrogens and androgens in male breast cancer. J Steroid Biochem 7:603\u2013609", "journal-title": "J Steroid Biochem"}, {"key": "12_CR13", "doi-asserted-by": "crossref", "first-page": "1873", "DOI": "10.1093/hmg/3.10.1873", "volume": "3", "author": "AH Carey", "year": "1994", "unstructured": "Carey AH, Waterworth D, Patel K et al (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873\u20131876", "journal-title": "Hum Mol Genet"}, {"key": "12_CR14", "first-page": "149", "volume": "7", "author": "G Carlsson", "year": "1981", "unstructured": "Carlsson G, Hafstrom L, Jonsson P (1981) Male breast cancer. Clin Oncol 7:149\u2013155", "journal-title": "Clin Oncol"}, {"key": "12_CR15", "first-page": "1326", "volume": "48", "author": "JT Casagrande", "year": "1988", "unstructured": "Casagrande JT, Hanisch R, Pike MC et al (1988) A case-control study of male breast cancer. Cancer Res 48:1326\u20131330", "journal-title": "Cancer Res"}, {"key": "12_CR16", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1093/jnci/92.3.261", "volume": "92", "author": "JR Cerhan", "year": "2000", "unstructured": "Cerhan JR, Kushi LH, Losom JE et al (2000) Twinship and risk of post-menopausal breast cancer. J Natl Cancer Inst 92:261\u2013265", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR17", "doi-asserted-by": "crossref", "first-page": "3181", "DOI": "10.1093/nar/22.15.3181", "volume": "22", "author": "NL Chamberlain", "year": "1994", "unstructured": "Chamberlain NL, Driver ED, Miesfeld RI (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181\u20133186", "journal-title": "Nucleic Acids Res"}, {"key": "12_CR18", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/j.ejmg.2007.11.001", "volume": "51", "author": "G Chodick", "year": "2008", "unstructured": "Chodick G, Struewing JP, Ron E et al (2008) Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence fromj 261 cases in Israel, 1976\u20131999. Eur J Med Genet 51:141\u2013147", "journal-title": "Eur J Med Genet"}, {"key": "12_CR19", "doi-asserted-by": "crossref", "first-page": "308", "DOI": "10.1097/01.SMJ.0000050686.54786.79", "volume": "97", "author": "K Coard", "year": "2004", "unstructured": "Coard K, McCartney T (2004) Bilateral synchronous carcinoma of the male breast in a patient receiving estrogen therapy for carcinoma of the prostate: cause or coincidence? South Med J 97:308\u2013310", "journal-title": "South Med J"}, {"key": "12_CR20", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1136/oem.55.9.599", "volume": "55", "author": "P Cocco", "year": "1998", "unstructured": "Cocco P, Figgs L, Dosemeci M et al (1998) Case-control study of occupational exposures and male breast cancer. Occup Environ Med 55:599\u2013604", "journal-title": "Occup Environ Med"}, {"key": "12_CR21", "doi-asserted-by": "crossref", "first-page": "1359", "DOI": "10.1038/bjc.1995.264", "volume": "71", "author": "B D\u2019Avanzo", "year": "1995", "unstructured": "D\u2019Avanzo B, La Vecchia C (1995) Risk factors for male breast cancer. Br J Cancer 71:1359\u20131362", "journal-title": "Br J Cancer"}, {"key": "12_CR22", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1136/jmg.39.4.225", "volume": "39", "author": "MM Jong De", "year": "2002", "unstructured": "De Jong MM, Nolte IM, te Meerman GJ et al (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39:225\u2013242", "journal-title": "J Med Genet"}, {"key": "12_CR23", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1093/oxfordjournals.aje.a116095", "volume": "134", "author": "PA Demers", "year": "1991", "unstructured": "Demers PA, Thomas DB, Rosenblatt KA (1991) Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol 134:340\u2013347", "journal-title": "Am J Epidemiol"}, {"key": "12_CR24", "doi-asserted-by": "crossref", "first-page": "498", "DOI": "10.1002/(SICI)1097-0142(19980801)83:3<498::AID-CNCR19>3.0.CO;2-R", "volume": "83", "author": "WL Donegan", "year": "1998", "unstructured": "Donegan WL, Redlich PN, Lang PG, Gall MT (1998) Carcinoma of the breast in males. A multiinstitutional survey. Cancer 83:498\u2013509", "journal-title": "Cancer"}, {"key": "12_CR25", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1023/A:1010639429207", "volume": "66", "author": "C Dong", "year": "2001", "unstructured": "Dong C, Hemminki K (2001) Second primary breast cancer in men. Br Cancer Res Treat 66:171\u2013172", "journal-title": "Br Cancer Res Treat"}, {"key": "12_CR26", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1080/028418601750288181", "volume": "40", "author": "M Ewertz", "year": "2001", "unstructured": "Ewertz M, Holmberg L, Tretli S et al (2001) Risk factors for male breast cancer \u2013 a case-control study from Scandinavia. Acta Oncol 40:467\u2013471", "journal-title": "Acta Oncol"}, {"key": "12_CR27", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1136/jmg.38.3.159", "volume": "38", "author": "JD Fackenthal", "year": "2001", "unstructured": "Fackenthal JD, Marsh DJ, Richardson AL et al (2001) Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 38:159\u2013164", "journal-title": "J Med Genet"}, {"key": "12_CR28", "unstructured": "Falchetti M, Lupi R, Rizzolo P et al (2007) BRCA1/2rerrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Br Cancer Res Treat PMID 17661168"}, {"key": "12_CR29", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1016/S0140-6736(88)91413-4", "volume": "i", "author": "IS Fentiman", "year": "1988", "unstructured": "Fentiman IS, Brame K, Chaudary MA et al (1988) Bromocriptine adjuvant treatment for operable breast cancer: a double-blind controlled pilot study. Lancet i:609\u2013610", "journal-title": "Lancet"}, {"key": "12_CR30", "doi-asserted-by": "crossref", "first-page": "1020", "DOI": "10.1016/0140-6736(90)91075-L", "volume": "335", "author": "IS Fentiman", "year": "1990", "unstructured": "Fentiman IS, Tirelli U, Monfardini S et al (1990) Cancer in the elderly: why so badly treated? Lancet 335:1020\u20131022", "journal-title": "Lancet"}, {"key": "12_CR31", "author": "IS Fentiman", "year": "1998", "unstructured": "Fentiman IS (1998) Diagnosis and treatment of breast cancer, Chapter 19 Martin Dunitz, London", "volume-title": "Diagnosis and treatment of breast cancer"}, {"key": "12_CR32", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1016/S0140-6736(06)68226-3", "volume": "367", "author": "IS Fentiman", "year": "2006", "unstructured": "Fentiman IS, Fourquet A, Hortobagyi G (2006) Male breast cancer. Lancet 367:595\u2013601", "journal-title": "Lancet"}, {"key": "12_CR33", "doi-asserted-by": "crossref", "first-page": "454", "DOI": "10.1007/BF03351047", "volume": "24", "author": "F Forloni", "year": "2001", "unstructured": "Forloni F, Giovilli K, Pecis S et al (2001) Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old man. Endocrinol Invest 24:454\u2013459", "journal-title": "Endocrinol Invest"}, {"key": "12_CR34", "doi-asserted-by": "crossref", "first-page": "1480", "DOI": "10.1200/JCO.2002.20.6.1480", "volume": "20", "author": "TS Frank", "year": "2002", "unstructured": "Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480\u20131490", "journal-title": "J Clin Oncol"}, {"key": "12_CR35", "first-page": "313", "volume": "60", "author": "LS Friedman", "year": "1997", "unstructured": "Friedman LS, Gayther SA, Kurosaki T et al (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60:313\u2013319", "journal-title": "Am J Hum Genet"}, {"key": "12_CR36", "doi-asserted-by": "crossref", "first-page": "956", "DOI": "10.1136/jcp.54.12.956", "volume": "54", "author": "S Gill", "year": "2001", "unstructured": "Gill S, Peston D, Vonderhaar BK, Shousha S (2001) Expression of prolactin receptors in normal, benign and malignant breast tissue: an immunological study. J Clin Pathol 54:956\u2013960", "journal-title": "J Clin Pathol"}, {"key": "12_CR37", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1002/cncr.20312", "volume": "101", "author": "SH Giordano", "year": "2004", "unstructured": "Giordano SH, Cohen DS, Buzdae AU et al (2004) Breast carcinoma in men. A population-based study. Cancer 101:51\u201357", "journal-title": "Cancer"}, {"issue": "6", "key": "12_CR38", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1038/sj.bjc.6600839", "volume": "88", "author": "K Gudmundsdottir", "year": "2003", "unstructured": "Gudmundsdottir K, Thoracius S, Jonasson JG et al (2003) CYP17 promoter polymorphism and breast cancer risk among males and females in relation to BRCA2 status. Br J Cancer 88(6):933\u2013936", "journal-title": "Br J Cancer"}, {"key": "12_CR39", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1023/B:CACO.0000036154.18162.43", "volume": "15", "author": "P Guenel", "year": "2004", "unstructured": "Guenel P, Cyr D, Sabroe S et al (2004) Alcohol drinking may increase the risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control 15:571\u2013580", "journal-title": "Cancer Causes Control"}, {"key": "12_CR40", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1007/BF00309236", "volume": "23", "author": "S Haga", "year": "1993", "unstructured": "Haga S, Watanabe O, Shimizu T et al (1993) Breast cancer in a male patient with prolactinoma. Surg Today 23:251\u2013255", "journal-title": "Surg Today"}, {"key": "12_CR41", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1002/(SICI)1097-0274(200004)37:4<349::AID-AJIM4>3.0.CO;2-L", "volume": "37", "author": "J Hansen", "year": "2000", "unstructured": "Hansen J (2000) Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med 37:349\u2013352", "journal-title": "Am J Ind Med"}, {"key": "12_CR42", "doi-asserted-by": "crossref", "first-page": "460", "DOI": "10.1136/jmg.8.4.460", "volume": "8", "author": "DG Harnden", "year": "1971", "unstructured": "Harnden DG, Maclean N, Langlands AO (1971) Carcinoma of the breast and Klinefelter\u2019s syndrome. J Med Gen 8:460\u2013461", "journal-title": "J Med Gen"}, {"key": "12_CR43", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1245/ASO.2004.01.001", "volume": "11", "author": "NC Hodgson", "year": "2004", "unstructured": "Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS (2004) Male breast cancer: is the incidence increasing? Ann Surg Oncol 11:751\u2013755", "journal-title": "Ann Surg Oncol"}, {"key": "12_CR44", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1023/A:1008869003012", "volume": "9", "author": "AW Hsing", "year": "1998", "unstructured": "Hsing AW, McLaughlin JK, Cocco P et al (1998) Risk factors for male breast cancer (United States). Cancer Causes Control 9:269\u2013276", "journal-title": "Cancer Causes Control"}, {"key": "12_CR45", "first-page": "4293", "volume": "17", "author": "R Hultborn", "year": "1997", "unstructured": "Hultborn R, Hanson C, Kopf I et al (1997) Prevalence of Klinefelter\u2019s syndrome in male breast cancer patients. Anticancer Res 17:4293\u20134297", "journal-title": "Anticancer Res"}, {"key": "12_CR46", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1111/j.1469-1809.1974.tb01843.x", "volume": "37", "author": "PS Jacobs", "year": "1974", "unstructured": "Jacobs PS, Melville M, Ratcliffe S, Keay AJ, Syme J (1974) A cytogenetic survey of 11680 newborn infants. Ann Hum Genet 37:359\u2013376", "journal-title": "Ann Hum Genet"}, {"key": "12_CR47", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1097/00008469-200206000-00009", "volume": "11", "author": "KC Johnson", "year": "2002", "unstructured": "Johnson KC, Pan S, Mao Y (2002) Risk factors for male breast cancer in Canada, 1994\u2013198. Eur J Cancer Prev 11:253\u2013263", "journal-title": "Eur J Cancer Prev"}, {"key": "12_CR48", "first-page": "446", "volume": "65", "author": "JG Jonasson", "year": "1996", "unstructured": "Jonasson JG, Agnarsson BA, Thorlacius S et al (1996) Male breast cancer in Iceland. Br J Cancer 65:446\u2013449", "journal-title": "Br J Cancer"}, {"key": "12_CR49", "first-page": "120", "volume": "72", "author": "PB Kahla", "year": "2005", "unstructured": "Kahla PB, Cassaro S, Vladimir FG et al (2005) Bilateral synchronous breast cancer in a male.Mt Sinai J Med 72:120\u2013123", "journal-title": "Mt Sinai J Med"}, {"key": "12_CR50", "doi-asserted-by": "crossref", "first-page": "615", "DOI": "10.1210/jcem-2-11-615", "volume": "2", "author": "HG Klinefelter", "year": "1942", "unstructured": "Klinefelter HG, Reifentein EC Jr, Albright F (1942) Syndrome characterized by gynecomastia, aspermatogenesis without a-Leydigism and increased secretion of follicle-stimulation hormone. J Clin Endocrinol Metab 2:615\u2013627", "journal-title": "J Clin Endocrinol Metab"}, {"key": "12_CR51", "first-page": "153", "volume": "11", "author": "J Lambley", "year": "2005", "unstructured": "Lambley J, Maguire E, Lam KY (2005) Synchronous bilateral breast cancer in an elderly man. Br J 11:153", "journal-title": "Br J"}, {"key": "12_CR52", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1002/ijc.2910510113", "volume": "51", "author": "C Vecchia La", "year": "1992", "unstructured": "La Vecchia C, Levi F, Lucchini F (1992) Descriptive epidemiology of male breast cancer in Europe. Int J Cancer 51:62\u201366", "journal-title": "Int J Cancer"}, {"key": "12_CR53", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1002/ijc.2910450415", "volume": "45", "author": "M-H Lenfant-Pejovic", "year": "1990", "unstructured": "Lenfant-Pejovic M-H, Mlika-Cabanne N, Bouchardy C et al (1990) Risk factors for male breast cancer : a Franco-Swiss case-control study. Int J Cancer 45:661\u2013665", "journal-title": "Int J Cancer"}, {"key": "12_CR54", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1038/ng1093-109", "volume": "5", "author": "JM Lobaccaro", "year": "1993", "unstructured": "Lobaccaro JM, Lumbruso S, Belon C et al (1993) Androgen receptor gene mutation in male breast cancer. Nat Genet 5:109\u2013110", "journal-title": "Nat Genet"}, {"key": "12_CR55", "doi-asserted-by": "crossref", "first-page": "1482", "DOI": "10.1016/0140-6736(92)92078-T", "volume": "339", "author": "DP Loomis", "year": "1992", "unstructured": "Loomis DP (1992) Cancer of breast among men in electrical occupations. Lancet 339:1482\u20131483", "journal-title": "Lancet"}, {"key": "12_CR56", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1016/j.ejca.2004.12.016", "volume": "41", "author": "E Lynge", "year": "2005", "unstructured": "Lynge E, Afonso N, Kaerlev L et al (2005) European multicentre case-control study on risk factors for rare cancers of unknown aetiology. Eur J Cancer 41:601\u2013612", "journal-title": "Eur J Cancer"}, {"key": "12_CR57", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1002/ajim.20160", "volume": "47", "author": "F Ma", "year": "2005", "unstructured": "Ma F, Fleming LE, Lee DJ et al (2005) Mortality in Florida firefighters, 1972 to 1999. Am J Ind Med 47:509\u2013517", "journal-title": "Am J Ind Med"}, {"key": "12_CR58", "first-page": "371", "volume": "74", "author": "K Mabuchi", "year": "1985", "unstructured": "Mabuchi K, Bross DS, Kessler II (1985) Risk factors for male breast cancer. J Natl Cancer Inst 74:371\u2013375", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR59", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1007/s10549-004-0781-6", "volume": "88", "author": "HE MacLean", "year": "2004", "unstructured": "MacLean HE, Brown RW, Beilin GL, Zajac JD (2004) Increased frequency of long androgen receptor CAG repeats in male breast cancers. Br Cancer Res Treat 88:239\u2013246", "journal-title": "Br Cancer Res Treat"}, {"key": "12_CR60", "doi-asserted-by": "crossref", "first-page": "1126", "DOI": "10.1093/jnci/92.14.1126", "volume": "92", "author": "AM Martin", "year": "2000", "unstructured": "Martin AM, Weber BL (2000) Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92:1126\u20131135", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR61", "first-page": "275", "volume": "4", "author": "JK McLaughlin", "year": "1988", "unstructured": "McLaughlin JK, Malker BR, Blot WJ et al (1988) Occupational risks for male breast cancer in Sweden. Br J Indust Med 4:275\u20136", "journal-title": "Br J Indust Med"}, {"key": "12_CR62", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1001/jama.1951.03670010011002", "volume": "146", "author": "JA McClure", "year": "1951", "unstructured": "McClure JA, Higgins CC (1951) Bilateral carcinoma of male breast after estrogen therapy. JAMA 146:7\u20139", "journal-title": "JAMA"}, {"key": "12_CR63", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1038/ng879", "volume": "31", "author": "H Meijers-Heijboer", "year": "2002", "unstructured": "Meijers-Heijboer H, van den Ouweland A, Klijn J et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55\u201359", "journal-title": "Nat Genet"}, {"key": "12_CR64", "doi-asserted-by": "crossref", "first-page": "1471", "DOI": "10.1002/cncr.22589", "volume": "109", "author": "ZA Nahleh", "year": "2007", "unstructured": "Nahleh ZA, Srikantiah R, Safa M et al (2007) Male breast cancer in the veterans affairs population: a comparative analysis. Cancer 109:1471\u20131477", "journal-title": "Cancer"}, {"key": "12_CR65", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1038/bjc.1983.208", "volume": "48", "author": "D Nirmul", "year": "1982", "unstructured": "Nirmul D, Pegoraro RJ, Jialal I et al (1982) The sex hormone profile of male patients with breast cancer. Br J Cancer 48:423\u2013427", "journal-title": "Br J Cancer"}, {"key": "12_CR66", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1002/ijc.11603", "volume": "108", "author": "T Ohayon", "year": "2004", "unstructured": "Ohayon T, Gasl I, Baruch RG, Szabo C, Friedman E (2004) CHEK2*1100delC and male breast cancer risk in Israel. Int J Cancer 108:479\u2013480", "journal-title": "Int J Cancer"}, {"key": "12_CR67", "first-page": "489", "volume": "55", "author": "EA Ojara", "year": "1978", "unstructured": "Ojara EA (1978) Carcinoma of the male breast in Mulago Hospital, Kampala. East Afr Med J 55:489\u2013491", "journal-title": "East Afr Med J"}, {"key": "12_CR68", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1007/BF02967643", "volume": "10", "author": "K Okada", "year": "2003", "unstructured": "Okada K, Kajiwara S, Tanaka H, Sakamoto G (2003) Synchronous bilateral non-invasive ductal carcinoma of the male breast: a case report. Br Cancer 10:163\u2013166", "journal-title": "Br Cancer"}, {"key": "12_CR69", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1186/1471-2407-2-26", "volume": "2", "author": "H Olsson", "year": "2002", "unstructured": "Olsson H, Bladstrom A, Alm P (2002) Male gynaecomastia and risk for malignant tumours \u2013 a cohort study. BMC Cancer 2:26\u201331", "journal-title": "BMC Cancer"}, {"key": "12_CR70", "doi-asserted-by": "crossref", "first-page": "2474", "DOI": "10.1016/j.ejca.2004.07.012", "volume": "40", "author": "D Palli", "year": "2005", "unstructured": "Palli D, Masala G, Mariani-Costantini R et al (2005) A gene-environment interaction between occupation and BRCA1/BRCA2 mutations in male breast cancer. Eur J Cancer 40:2474\u20132479", "journal-title": "Eur J Cancer"}, {"key": "12_CR71", "doi-asserted-by": "crossref", "first-page": "1234", "DOI": "10.1054/bjoc.2000.1467", "volume": "83", "author": "E Petridou", "year": "2000", "unstructured": "Petridou E, Glokas G, Kuper H et al (2000) Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece. Br J Cancer 83:1234\u20131237", "journal-title": "Br J Cancer"}, {"key": "12_CR72", "doi-asserted-by": "crossref", "first-page": "276", "DOI": "10.1002/1097-0274(200103)39:3<276::AID-AJIM1015>3.0.CO;2-B", "volume": "39", "author": "M Pollan", "year": "2001", "unstructured": "Pollan M, Gustavsson P, Floderus B (2001) Breast cancer, occupation, and exposure to electromagnetic fields among Swedish men. Am J Ind Med 39:276\u2013285", "journal-title": "Am J Ind Med"}, {"key": "12_CR73", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1136/jech.39.4.330", "volume": "39", "author": "WH Price", "year": "1985", "unstructured": "Price WH, Clayton JF, Wilson J, Collyer S, De Mey R (1985) Causes of death in X chromatin positive males (Klinefelter\u2019s syndrome). J Epidemiol Community Health 39:330\u2013336", "journal-title": "J Epidemiol Community Health"}, {"key": "12_CR74", "doi-asserted-by": "crossref", "first-page": "474", "DOI": "10.1038/bjc.1980.72", "volume": "41", "author": "GG Ribeiro", "year": "1980", "unstructured": "Ribeiro GG, Phillips HU, Skinner LG (1980) Serum oestradiol-17\u03b2, testosterone, luteinising hormone and follicle-stimulating hormone in males with breast cancer. Br J Cancer 41:474\u2013477", "journal-title": "Br J Cancer"}, {"key": "12_CR75", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.1093/jnci/dji097", "volume": "97", "author": "E Ron", "year": "2005", "unstructured": "Ron E, Ikeda T, Preston DL, Tokuaka S (2005) Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst 97:603\u2013605", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR76", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1023/A:1008808925665", "volume": "10", "author": "KA Rosenblatt", "year": "1999", "unstructured": "Rosenblatt KA, Thomas DB, Jiminez LM et al (1999) The relationship between diet and breast cancer in men (United States). Cancer Causes Control 10:107\u2013113", "journal-title": "Cancer Causes Control"}, {"key": "12_CR77", "doi-asserted-by": "crossref", "first-page": "1281", "DOI": "10.1093/carcin/21.7.1281", "volume": "21", "author": "A Rundle", "year": "2000", "unstructured": "Rundle A, Tang D, Hibshoosh H et al (2000) The relationship between genetic damage from polycylic aromatic hydrocarbons in breast tissue and normal tissue. Carcinogenesis 21:1281\u20131289", "journal-title": "Carcinogenesis"}, {"key": "12_CR78", "doi-asserted-by": "crossref", "first-page": "R10", "DOI": "10.1186/bcr1643", "volume": "9", "author": "S Safram-Hoang", "year": "2007", "unstructured": "Safram-Hoang S, Ziogas A, Anton-Culver H (2007) Risk of second primary cancer in men with breast cancer. Br Cancer Res 9:R10 (doi:b10,1186/bcr1643)", "journal-title": "Br Cancer Res"}, {"key": "12_CR79", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1002/ijc.2910530403", "volume": "53", "author": "AJ Sasco", "year": "1993", "unstructured": "Sasco AJ, Lowenfels AB, Pasker-de Jong J (1993) Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 53:538\u2013549", "journal-title": "Int J Cancer"}, {"key": "12_CR80", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1016/0022-4731(73)90064-2", "volume": "4", "author": "O Scheike", "year": "1973", "unstructured": "Scheike O, Svenstrop B, Frandsen VA (1973) Male breast cancer II. Metabolism of oestradiol-17\u03b2 in men with breast cancer. J Steroid Biochem 4:489\u2013491", "journal-title": "J Steroid Biochem"}, {"key": "12_CR81", "doi-asserted-by": "crossref", "first-page": "890", "DOI": "10.2105/AJPH.53.6.890", "volume": "53", "author": "D Schottenfeld", "year": "1963", "unstructured": "Schottenfeld D, Lilienfeld AM, Diamond H (1963) Some observations on the epidemiology of breast cancer among males. Am J Public Health 53:890\u2013897", "journal-title": "Am J Public Health"}, {"key": "12_CR82", "first-page": "1200", "volume": "12", "author": "TR Smith", "year": "2003", "unstructured": "Smith TR, Levine EA, Perrier ND et al (2003) DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12:1200\u20131204", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "12_CR83", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1097/00008469-200504000-00016", "volume": "14", "author": "HT S\u00f8rensen", "year": "2005", "unstructured": "S\u00f8rensen HT, Olsen ML, Mellemkjaer L et al (2005) The intrauterine origin of male breast cancer: a birth order study in Denmark. Eur J Cancer Prev 14:185\u2013186", "journal-title": "Eur J Cancer Prev"}, {"key": "12_CR84", "first-page": "816", "volume": "17", "author": "R Steinitz", "year": "1981", "unstructured": "Steinitz R, Katz L, Ben-Hur M (1981) Male breast cancer in Israel: selected epidemiologic aspects. J Med Sci 17:816\u2013821", "journal-title": "J Med Sci"}, {"key": "12_CR85", "doi-asserted-by": "crossref", "first-page": "1204", "DOI": "10.1093/jnci/dji240", "volume": "97", "author": "AJ Swerdlow", "year": "2005", "unstructured": "Swerdlow AJ, Schoemaker MJ, Higgins CD et al (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97:1204\u20131210", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR86", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1136/bmj.2.5597.83", "volume": "2", "author": "WSC Symmers", "year": "1968", "unstructured": "Symmers WSC (1968) Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br Med J 2:83\u201385", "journal-title": "Br Med J"}, {"key": "12_CR87", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1023/A:1021369508561", "volume": "77", "author": "K Syrj\u00e4koski", "year": "2003", "unstructured": "Syrj\u00e4koski K, Hyytinen E-J, Kuukasj\u00e4rvi T et al (2003) Androgen receptor gene alterations in Finnish male breast cancer.Br Cancer Res Treat 77:167\u2013170", "journal-title": "Br Cancer Res Treat"}, {"key": "12_CR88", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1002/ijc.11384", "volume": "108", "author": "K Syrj\u00e4koski", "year": "2004", "unstructured": "Syrj\u00e4koski K, Kuukasj\u00e4rvi T, Auvinen A, Kallioniemi O-P (2004) CHEK2 1100delC is not a risk factor for male breast cancer population. Int J Cancer 108:475\u2013476", "journal-title": "Int J Cancer"}, {"key": "12_CR89", "doi-asserted-by": "crossref", "first-page": "1811", "DOI": "10.1093/jnci/djm203", "volume": "99", "author": "YC Tai", "year": "2007", "unstructured": "Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99:1811\u20131814", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR90", "doi-asserted-by": "crossref", "first-page": "1139", "DOI": "10.1038/sj.bjc.6603689", "volume": "96", "author": "EF Taylor", "year": "2007", "unstructured": "Taylor EF, Burley VJ, Greenwood DC, Cade JE (2007) Meat consumption and risk of breast cancer in the UK Women\u2019s Cohort Study. Br J Cancer 96:1139\u20131146", "journal-title": "Br J Cancer"}, {"key": "12_CR91", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.3816/CBC.2007.n.021", "volume": "7", "author": "J Tchou", "year": "2007", "unstructured": "Tchou J, Ward MR, Volpe P et al (2007) Large genomic rearrangements in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clin Breast Cancer 7:627\u2013633", "journal-title": "Clin Breast Cancer"}, {"key": "12_CR92", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1038/ng879", "volume": "31", "author": "The CHEK2 Breast Cancer Consortium", "year": "2002", "unstructured": "The CHEK2 Breast Cancer Consortium (2002) Low penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 and BRCA2 mutations. Nat Genet 31:55\u201359", "journal-title": "Nat Genet"}, {"key": "12_CR93", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1093/jnci/djk094", "volume": "99", "author": "ACM Thi\u00e9baut", "year": "2007", "unstructured": "Thi\u00e9baut ACM, Kipnis V, Chang S-C et al (2007) Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst 99:451\u2013462", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR94", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1093/oxfordjournals.aje.a116360", "volume": "135", "author": "DB Thomas", "year": "1992", "unstructured": "Thomas DB, Jimenez LM, McTiernan A et al (1992) Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 135:734\u2013748", "journal-title": "Am J Epidemiol"}, {"key": "12_CR95", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1007/BF01830721", "volume": "5", "author": "DB Thomas", "year": "1994", "unstructured": "Thomas DB, Rosenblatt K, Jiminez LM et al (1994) Ionizing radiation and breast cancer in men (United States). Cancer Causes Control 5:9\u201314", "journal-title": "Cancer Causes Control"}, {"key": "12_CR96", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1080/03014469800005432", "volume": "25", "author": "HV Thomas", "year": "1998", "unstructured": "Thomas HV, Murphy MF, Key TJ et al (1998) Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Human Biol 25:69\u201375", "journal-title": "Ann Human Biol"}, {"key": "12_CR97", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1093/jnci/djh077", "volume": "96", "author": "R Travis", "year": "2004", "unstructured": "Travis R, Allen DS, Fentiman IS, Key TJ (2004) Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 96:475\u2013482", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR98", "doi-asserted-by": "crossref", "first-page": "1083", "DOI": "10.1002/1097-0142(195811/12)11:6<1083::AID-CNCR2820110602>3.0.CO;2-9", "volume": "11", "author": "N Treves", "year": "1958", "unstructured": "Treves N (1958) Gynecomastia: the origins of mammary swelling in the male: an analysis of 406 patients with breast hypertrophy, 525 with testicular tumors and 13 with adrenal neoplasms. Cancer 11:1083\u20131102", "journal-title": "Cancer"}, {"key": "12_CR99", "doi-asserted-by": "crossref", "first-page": "1604", "DOI": "10.1016/0140-6736(90)91000-Z", "volume": "335", "author": "D Trichopoulos", "year": "1990", "unstructured": "Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero? Lancet 335:1604", "journal-title": "Lancet"}, {"key": "12_CR100", "doi-asserted-by": "crossref", "first-page": "1596", "DOI": "10.1016/0140-6736(90)93387-5", "volume": "336", "author": "T Tynes", "year": "1990", "unstructured": "Tynes T, Andersen A (1990) Electromagnetic fields and male breast cancer. Lancet 336:1596", "journal-title": "Lancet"}, {"key": "12_CR101", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1002/(SICI)1096-9098(199701)64:1<74::AID-JSO14>3.0.CO;2-W", "volume": "64", "author": "MD Volm", "year": "1997", "unstructured": "Volm MD, Talamonti MS, Thangavelu M, Gradishar WK (1997) Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol 64:74\u201378", "journal-title": "J Surg Oncol"}, {"key": "12_CR102", "first-page": "15", "year": "1976", "unstructured": "Waterhouse J, Muir C, Correa P, Powell JR (eds) (1976) Cancer incidence in five continents, vol 3. IARC Sci Publ, Lyon, p 15", "volume-title": "Cancer incidence in five continents"}, {"key": "12_CR103", "doi-asserted-by": "crossref", "first-page": "360", "DOI": "10.1002/(SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W", "volume": "71", "author": "E Weiderpass", "year": "1997", "unstructured": "Weiderpass E, Gridley G, Persson I et al (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71:360\u2013363", "journal-title": "Int J Cancer"}, {"key": "12_CR104", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1023/A:1011216502678", "volume": "12", "author": "E Weiderpass", "year": "2001", "unstructured": "Weiderpass E, Ye W, Adami HO et al (2001) Breast cancer risk in male alcoholics in Sweden. Cancer Causes Control 12:661\u2013664", "journal-title": "Cancer Causes Control"}, {"key": "12_CR105", "doi-asserted-by": "crossref", "first-page": "1231", "DOI": "10.1054/bjoc.2000.1468", "volume": "83", "author": "DC Whiteman", "year": "2000", "unstructured": "Whiteman DC, Murphy MF, Verkasalo PK et al (2000) Breast cancer risk in male twins: joint analysers of four twin cohorts in Denmark, Finland, Sweden and the United States. Br J Cancer 83:1231\u20131233", "journal-title": "Br J Cancer"}, {"key": "12_CR106", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1038/ng1092-132", "volume": "2", "author": "R Wooster", "year": "1992", "unstructured": "Wooster R, Mangion J, Eeles R et al (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2:132\u2013134", "journal-title": "Nat Genet"}, {"key": "12_CR107", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1038/sj.bjc.6690663", "volume": "81", "author": "IE Young", "year": "1999", "unstructured": "Young IE, Kurian KM, Annink C et al (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81:141\u2013143", "journal-title": "Br J Cancer"}, {"key": "12_CR108", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1136/jmg.37.2.139", "volume": "37", "author": "IE Young", "year": "2000", "unstructured": "Young IE, Kurian FM, Mackenzie MAF et al (2000a) The CAG repeat within the androgen receptor in male breast cancer patients. J Med Genet 37:139\u2013140", "journal-title": "J Med Genet"}, {"key": "12_CR109", "doi-asserted-by": "crossref", "first-page": "1247", "DOI": "10.1054/bjoc.1999.1085", "volume": "82", "author": "IE Young", "year": "2000", "unstructured": "Young IE, Kurian KM, Mackenzie MAF et al (2000b) A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer. Br J Cancer 82:1247\u20131248", "journal-title": "Br J Cancer"}], "container-title": ["Breast Cancer Epidemiology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4419-0685-4_12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 10]], "date-time": "2019-03-10T12:17:58Z", "timestamp": 1552220278000}, "score": 33.63489, "issued": {"date-parts": [[2009, 8, 3]]}, "ISBN": ["9781441906847", "9781441906854"], "references-count": 109, "URL": "http://dx.doi.org/10.1007/978-1-4419-0685-4_12", "relation": {"cites": []}}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T23:28:47Z", "timestamp": 1574810927332}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006, 9, 1]]}, "DOI": "10.21236/ada462888", "type": "report", "created": {"date-parts": [[2017, 7, 14]], "date-time": "2017-07-14T17:10:56Z", "timestamp": 1500052256000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Disruption of Brca2-Rad51 Complex in Breast Cancer Cells: Therapeutic Implications"], "prefix": "10.21236", "author": [{"given": "Raquel S.", "family": "Aloyz", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 14]], "date-time": "2017-07-14T17:10:56Z", "timestamp": 1500052256000}, "score": 33.58034, "subtitle": [""], "issued": {"date-parts": [[2006, 9, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada462888"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T19:18:42Z", "timestamp": 1574882322972}, "reference-count": 95, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 9, 28]], "date-time": "2018-09-28T00:00:00Z", "timestamp": 1538092800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2019, 1]]}, "DOI": "10.1007/s10549-018-4921-9", "type": "journal-article", "created": {"date-parts": [[2018, 9, 28]], "date-time": "2018-09-28T07:02:20Z", "timestamp": 1538118140000}, "page": "37-48", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Male breast cancer: a disease distinct from female breast cancer"], "prefix": "10.1007", "volume": "173", "author": [{"ORCID": "http://orcid.org/0000-0002-3600-3751", "authenticated-orcid": false, "given": "Ayca", "family": "Gucalp", "sequence": "first", "affiliation": []}, {"given": "Tiffany A.", "family": "Traina", "sequence": "additional", "affiliation": []}, {"given": "Joel R.", "family": "Eisner", "sequence": "additional", "affiliation": []}, {"given": "Joel S.", "family": "Parker", "sequence": "additional", "affiliation": []}, {"given": "Sara R.", "family": "Selitsky", "sequence": "additional", "affiliation": []}, {"given": "Ben H.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Anthony D.", "family": "Elias", "sequence": "additional", "affiliation": []}, {"given": "Edwina S.", "family": "Baskin-Bey", "sequence": "additional", "affiliation": []}, {"given": "Fatima", "family": "Cardoso", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 9, 28]]}, "reference": [{"issue": "12", "key": "4921_CR1", "doi-asserted-by": "publisher", "first-page": "2114", "DOI": "10.1200/JCO.2009.25.5729", "volume": "28", "author": "LA Korde", "year": "2010", "unstructured": "Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF et al (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28(12):2114\u20132122", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "4921_CR2", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1517/14656566.8.2.193", "volume": "8", "author": "B Cutuli", "year": "2007", "unstructured": "Cutuli B (2007) Strategies in treating male breast cancer. Expert Opin Pharmacother 8(2):193\u2013202", "journal-title": "Expert Opin Pharmacother"}, {"issue": "3", "key": "4921_CR3", "first-page": "663", "volume": "24", "author": "R Gennari", "year": "2004", "unstructured": "Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M et al (2004) Male breast cancer: a special therapeutic problem. Anything new? (Review). Int J Oncol 24(3):663\u2013670", "journal-title": "Int J Oncol"}, {"issue": "9510", "key": "4921_CR4", "doi-asserted-by": "publisher", "first-page": "595", "DOI": "10.1016/S0140-6736(06)68226-3", "volume": "367", "author": "IS Fentiman", "year": "2006", "unstructured": "Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367(9510):595\u2013604", "journal-title": "Lancet"}, {"issue": "2", "key": "4921_CR5", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1016/j.canrad.2008.11.011", "volume": "13", "author": "A Yoney", "year": "2009", "unstructured": "Yoney A, Kucuk A, Unsal M (2009) Male breast cancer: a retrospective analysis. Cancer Radiother 13(2):103\u2013107", "journal-title": "Cancer Radiother"}, {"issue": "1", "key": "4921_CR6", "first-page": "20", "volume": "14", "author": "JR Weiss", "year": "2005", "unstructured": "Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 14(1):20\u201326", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"issue": "5", "key": "4921_CR7", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1007/s00428-006-0305-3", "volume": "449", "author": "AM Burga", "year": "2006", "unstructured": "Burga AM, Fadare O, Lininger RA, Tavassoli FA (2006) Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch 449(5):507\u2013512", "journal-title": "Virchows Arch"}, {"key": "4921_CR8", "doi-asserted-by": "publisher", "first-page": "1068", "DOI": "10.4236/ijcm.2014.517138", "volume": "5", "author": "MHSE Darkeh", "year": "2014", "unstructured": "Darkeh MHSE, Azavedo E (2014) Male breast cancer clinical features, risk factors, and current diagnostic and therapeutic approaches. Int J Clin Med 5:1068\u20131086", "journal-title": "Int J Clin Med"}, {"key": "4921_CR9", "unstructured": "Key statistics for breast cancer in men. \n                    http://www.cancer.org/cancer/breast-cancer-in-men/about/key-statistics.html\n                    \n                  . Accessed 5 March 2018"}, {"key": "4921_CR10", "unstructured": "How common is breast cancer? \n                    http://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html\n                    \n                  . Accessed 5 March 2018"}, {"key": "4921_CR11", "unstructured": "SEER*Explorer: an interactive website for SEER cancer statistics. \n                    http://www.seer.cancer.gov/explorer/\n                    \n                  . Accessed 16 July 2018"}, {"key": "4921_CR12", "unstructured": "Howlader N, Noone AM, Krapcho M, Miller DBK, Altekruse SF, Kosary CL et al (2016) SEER cancer statistics review, 1975\u20132013. 2016, National Cancer Institute: Bethesda, MD"}, {"key": "4921_CR13", "unstructured": "Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL et al (2017) SEER cancer statistics review, 1975\u20132014. 2017, National Cancer Institute: Bethesda, MD"}, {"key": "4921_CR14", "doi-asserted-by": "publisher", "first-page": "1298", "DOI": "10.1634/theoncologist.2016-0022", "volume": "21", "author": "F Giotta", "year": "2016", "unstructured": "Giotta F, Acito L, Candeloro G, Del Medico P, Gadaleta-Caldarola G, Giordano G et al (2016) Eribulin in male patients with breast cancer: the first report of clinical outcomes. Oncologist 21:1298\u20131305", "journal-title": "Oncologist"}, {"issue": "3", "key": "4921_CR15", "doi-asserted-by": "publisher", "first-page": "498", "DOI": "10.1002/(SICI)1097-0142(19980801)83:3<498::AID-CNCR19>3.0.CO;2-R", "volume": "83", "author": "WL Donegan", "year": "1998", "unstructured": "Donegan WL, Redlich PN, Lang PJ, Gall MT (1998) Carcinoma of the breast in males: a multiinstitutional survey. Cancer 83(3):498\u2013509", "journal-title": "Cancer"}, {"issue": "3", "key": "4921_CR16", "doi-asserted-by": "publisher", "first-page": "490", "DOI": "10.1002/(SICI)1097-0142(19960201)77:3<490::AID-CNCR10>3.0.CO;2-#", "volume": "77", "author": "MG Joshi", "year": "1996", "unstructured": "Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ et al (1996) Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 77(3):490\u2013498", "journal-title": "Cancer"}, {"issue": "2", "key": "4921_CR17", "doi-asserted-by": "publisher", "first-page": "554", "DOI": "10.1007/s12032-011-9978-9", "volume": "29", "author": "UY Arslan", "year": "2012", "unstructured": "Arslan UY, Oksuzoglu B, Ozdemir N, Aksoy S, Alkis N, Gok A et al (2012) Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol 29(2):554\u2013560", "journal-title": "Med Oncol"}, {"issue": "2", "key": "4921_CR18", "doi-asserted-by": "publisher", "first-page": "232", "DOI": "10.1200/JCO.2009.23.8162", "volume": "28", "author": "WF Anderson", "year": "2010", "unstructured": "Anderson WF, Jatoi I, Tse J, Rosenberg PS (2010) Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 28(2):232\u2013239", "journal-title": "J Clin Oncol"}, {"issue": "4 Supplement", "key": "4921_CR19", "first-page": "P5", "volume": "78", "author": "SH Giordano", "year": "2018", "unstructured": "Giordano SH, Schr\u00f6der CP, Poncet C, van Leeuwen-Stok E, Linderholm B, Abreu MH et al (2018) Clinical and biological characterization of male breast cancer (BC) EORTC 10085/TBCRC 029/BOOG 2013-02/BIG 2\u201307: baseline results from the prospective registry. Can Res 78(4 Supplement):P5\u2013P23", "journal-title": "Can Res"}, {"issue": "2", "key": "4921_CR20", "first-page": "405", "volume": "29", "author": "F Cardoso", "year": "2018", "unstructured": "Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P et al (2018) Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol 29(2):405\u2013417", "journal-title": "Ann Oncol"}, {"issue": "1", "key": "4921_CR21", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1002/cncr.20312", "volume": "101", "author": "SH Giordano", "year": "2004", "unstructured": "Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN (2004) Breast carcinoma in men: a population-based study. Cancer 101(1):51\u201357", "journal-title": "Cancer"}, {"issue": "6", "key": "4921_CR22", "doi-asserted-by": "publisher", "first-page": "1434", "DOI": "10.1093/annonc/mdt025", "volume": "24", "author": "KJ Ruddy", "year": "2013", "unstructured": "Ruddy KJ, Winer EP (2013) Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 24(6):1434\u20131443", "journal-title": "Ann Oncol"}, {"issue": "4", "key": "4921_CR23", "first-page": "991", "volume": "40", "author": "RB Everson", "year": "1980", "unstructured": "Everson RB, Lippman ME, Thompson EB, McGuire WL, Wittliff JL, De Sombre ER et al (1980) Clinical correlations of steroid receptors and male breast cancer. Cancer Res 40(4):991\u2013997", "journal-title": "Cancer Res"}, {"issue": "1", "key": "4921_CR24", "doi-asserted-by": "publisher", "first-page": "R31", "DOI": "10.1186/bcr3116", "volume": "14", "author": "I Johansson", "year": "2012", "unstructured": "Johansson I, Nilsson C, Berglund P, Lauss M, Ringner M, Olsson H et al (2012) Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Res 14(1):R31", "journal-title": "Breast Cancer Res"}, {"issue": "3", "key": "4921_CR25", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1007/s10549-010-1262-8", "volume": "129", "author": "I Johansson", "year": "2011", "unstructured": "Johansson I, Nilsson C, Berglund P, Strand C, Jonsson G, Staaf J et al (2011) High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat 129(3):747\u2013760", "journal-title": "Breast Cancer Res Treat"}, {"issue": "15 Suppl", "key": "4921_CR26", "doi-asserted-by": "publisher", "first-page": "1083", "DOI": "10.1200/jco.2015.33.15_suppl.1083", "volume": "33", "author": "JS Parker", "year": "2015", "unstructured": "Parker JS, Peterson AC, Tudor IC, Hoffman J, Uppal H (2015) A novel biomarker to predict sensitivity to enzalutamide (ENZA) in TNBC. J Clin Oncol 33(15 Suppl):1083", "journal-title": "J Clin Oncol"}, {"issue": "8", "key": "4921_CR27", "doi-asserted-by": "publisher", "first-page": "1160", "DOI": "10.1200/JCO.2008.18.1370", "volume": "27", "author": "JS Parker", "year": "2009", "unstructured": "Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27(8):1160\u20131167", "journal-title": "J Clin Oncol"}, {"issue": "16", "key": "4921_CR28", "doi-asserted-by": "publisher", "first-page": "4045", "DOI": "10.1158/1078-0432.CCR-15-2840", "volume": "22", "author": "S Piscuoglio", "year": "2016", "unstructured": "Piscuoglio S, Ng CK, Murray MP, Guerini-Rocco E, Martelotto LG, Geyer FC et al (2016) The genomic landscape of male breast cancers. Clin Cancer Res 22(16):4045\u20134056", "journal-title": "Clin Cancer Res"}, {"issue": "3", "key": "4921_CR29", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1159/000136825", "volume": "3", "author": "C Rudlowski", "year": "2008", "unstructured": "Rudlowski C (2008) Male breast cancer. Breast Care 3(3):183\u2013189", "journal-title": "Breast Care"}, {"issue": "Suppl 8", "key": "4921_CR30", "doi-asserted-by": "publisher", "first-page": "viii75", "DOI": "10.1093/annonc/mdt316", "volume": "24", "author": "P Rizzolo", "year": "2013", "unstructured": "Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K, Falchetti M et al (2013) Male breast cancer: genetics, epigenetics, and ethical aspects. Ann Oncol 24(Suppl 8):viii75\u2013viii82", "journal-title": "Ann Oncol"}, {"issue": "3", "key": "4921_CR31", "doi-asserted-by": "publisher", "first-page": "676", "DOI": "10.1086/301749", "volume": "62", "author": "D Ford", "year": "1998", "unstructured": "Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676\u2013689", "journal-title": "Am J Hum Genet"}, {"issue": "1", "key": "4921_CR32", "doi-asserted-by": "publisher", "first-page": "54", "DOI": "10.4065/72.1.54", "volume": "72", "author": "MH Greene", "year": "1997", "unstructured": "Greene MH (1997) Genetics of breast cancer. Mayo Clin Proc 72(1):54\u201365", "journal-title": "Mayo Clin Proc"}, {"issue": "1", "key": "4921_CR33", "doi-asserted-by": "publisher", "first-page": "15", "DOI": "10.1186/s13058-016-0671-y", "volume": "18", "author": "V Silvestri", "year": "2016", "unstructured": "Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY et al (2016) Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res 18(1):15", "journal-title": "Breast Cancer Res"}, {"issue": "1", "key": "4921_CR34", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1007/s10549-007-9689-2", "volume": "110", "author": "M Falchetti", "year": "2008", "unstructured": "Falchetti M, Lupi R, Rizzolo P, Ceccarelli K, Zanna I, Calo V et al (2008) BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat 110(1):161\u2013167", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "4921_CR35", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1007/s10549-010-0797-z", "volume": "122", "author": "V Silvestri", "year": "2010", "unstructured": "Silvestri V, Rizzolo P, Zanna I, Falchetti M, Masala G, Bianchi S et al (2010) PALB2 mutations in male breast cancer: a population-based study in Central Italy. Breast Cancer Res Treat 122(1):299\u2013301", "journal-title": "Breast Cancer Res Treat"}, {"issue": "4 Suppl", "key": "4921_CR36", "first-page": "PD7", "volume": "78", "author": "KJ Vogel Postula", "year": "2018", "unstructured": "Vogel Postula KJ, Andolina LM, Theobald K, McGill AK, Sutcliffe E, Arvai KJ et al (2018) The role of multi-gene hereditary cancer panels in male patients with breast cancer. Cancer Res 78(4 Suppl):PD7\u2013P11", "journal-title": "Cancer Res"}, {"issue": "1", "key": "4921_CR37", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1038/sj.bjc.6690663", "volume": "81", "author": "IE Young", "year": "1999", "unstructured": "Young IE, Kurian KM, Annink C, Kunkler IH, Anderson VA, Cohen BB et al (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81(1):141\u2013143", "journal-title": "Br J Cancer"}, {"issue": "6", "key": "4921_CR38", "doi-asserted-by": "publisher", "first-page": "933", "DOI": "10.1038/sj.bjc.6600839", "volume": "88", "author": "K Gudmundsdottir", "year": "2003", "unstructured": "Gudmundsdottir K, Thorlacius S, Jonasson JG, Sigfusson BF, Tryggvadottir L, Eyfjord JE (2003) CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status. Br J Cancer 88(6):933\u2013936", "journal-title": "Br J Cancer"}, {"issue": "11", "key": "4921_CR39", "doi-asserted-by": "publisher", "first-page": "2237", "DOI": "10.1158/1055-9965.EPI-07-0589", "volume": "16", "author": "VW Setiawan", "year": "2007", "unstructured": "Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D et al (2007) CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 16(11):2237\u20132246", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"issue": "4", "key": "4921_CR40", "doi-asserted-by": "publisher", "first-page": "R101", "DOI": "10.1186/bcr3220", "volume": "14", "author": "R Kornegoor", "year": "2012", "unstructured": "Kornegoor R, Moelans CB, Verschuur-Maes AH, Hogenes M, de Bruin PC, Oudejans JJ et al (2012) Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification. Breast Cancer Res 14(4):R101", "journal-title": "Breast Cancer Res"}, {"issue": "6D", "key": "4921_CR41", "first-page": "4293", "volume": "17", "author": "R Hultborn", "year": "1997", "unstructured": "Hultborn R, Hanson C, Kopf I, Verbiene I, Warnhammar E, Weimarck A (1997) Prevalence of Klinefelter\u2019s syndrome in male breast cancer patients. Anticancer Res 17(6D):4293\u20134297", "journal-title": "Anticancer Res"}, {"issue": "1", "key": "4921_CR42", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1001/jama.1951.03670010011002", "volume": "146", "author": "J McClure", "year": "1951", "unstructured": "McClure J, Higgins C (1951) Bilateral carcinoma of male breast after estrogen therapy. J Am Med Assoc 146(1):7\u20139", "journal-title": "J Am Med Assoc"}, {"issue": "5597", "key": "4921_CR43", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1136/bmj.2.5597.83", "volume": "2", "author": "WS Symmers", "year": "1968", "unstructured": "Symmers WS (1968) Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br Med J 2(5597):83\u201385", "journal-title": "Br Med J"}, {"issue": "2", "key": "4921_CR44", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1016/j.critrevonc.2009.04.003", "volume": "73", "author": "L Ottini", "year": "2010", "unstructured": "Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A (2010) Male breast cancer. Crit Rev Oncol Hematol 73(2):141\u2013155", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "4921_CR45", "unstructured": "Giordano S, Schroder C, Poncet C, van Leeuwen-Stok E, Linderholm B, Abreu MH et al (2017) Clinical and biological characterization of male breast cancer (MBC) EORTC 10085/TBCRC023: baseline results from the prospective registry. Presented at the 2017 San Antonio Breast Cancer Symposium. December 5\u20139, 2017: San Antonio, Texas, USA. Poster P5-23-01"}, {"issue": "11", "key": "4921_CR46", "doi-asserted-by": "publisher", "first-page": "1421", "DOI": "10.1001/jama.289.11.1421", "volume": "289", "author": "CI Li", "year": "2003", "unstructured": "Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11):1421\u20131424", "journal-title": "JAMA"}, {"issue": "7", "key": "4921_CR47", "doi-asserted-by": "publisher", "first-page": "924", "DOI": "10.1038/modpathol.2011.54", "volume": "24", "author": "LC Collins", "year": "2011", "unstructured": "Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM (2011) Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses\u2019 Health Study. Mod Pathol 24(7):924\u2013931", "journal-title": "Mod Pathol"}, {"key": "4921_CR48", "doi-asserted-by": "publisher", "first-page": "928562", "DOI": "10.1155/2013/928562", "volume": "2013", "author": "F Karami", "year": "2013", "unstructured": "Karami F, Mehdipour P (2013) A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int 2013:928562", "journal-title": "Biomed Res Int"}, {"issue": "3", "key": "4921_CR49", "doi-asserted-by": "publisher", "first-page": "575", "DOI": "10.1007/s10549-016-4085-4", "volume": "161", "author": "M Pritzlaff", "year": "2017", "unstructured": "Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS et al (2017) Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat 161(3):575\u2013586", "journal-title": "Breast Cancer Res Treat"}, {"key": "4921_CR50", "author": "M Liang", "year": "2018", "unstructured": "Liang M, Zhang Y, Sun C, Rizeq FK, Min M, Shi T et al (2018) Association between CHEK2*1100delC and breast cancer: a systematic review and meta-analysis. Mol Diagn Ther. \n                    https://doi.org/10.1007/s40291-018-0344-x", "journal-title": "Mol Diagn Ther", "DOI": "10.1007/s40291-018-0344-x", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "4921_CR51", "doi-asserted-by": "publisher", "first-page": "R27", "DOI": "10.1530/ERC-16-0225", "volume": "24", "author": "TM Severson", "year": "2017", "unstructured": "Severson TM, Zwart W (2017) A review of estrogen receptor/androgen receptor genomics in male breast cancer. Endocr Relat Cancer 24(3):R27\u2013R34", "journal-title": "Endocr Relat Cancer"}, {"issue": "52", "key": "4921_CR52", "first-page": "87532", "volume": "7", "author": "Q Wu", "year": "2016", "unstructured": "Wu Q, Li J, Zhu S, Wu J, Li X, Liu Q et al (2016) Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype. Oncotarget 7(52):87532\u201387542", "journal-title": "Oncotarget"}, {"issue": "10", "key": "4921_CR53", "doi-asserted-by": "publisher", "first-page": "1079", "DOI": "10.1001/archsurg.139.10.1079", "volume": "139", "author": "MB El-Tamer", "year": "2004", "unstructured": "El-Tamer MB, Komenaka IK, Troxel A, Li H, Joseph KA, Ditkoff BA et al (2004) Men with breast cancer have better disease-specific survival than women. Arch Surg 139(10):1079\u20131082", "journal-title": "Arch Surg"}, {"issue": "4", "key": "4921_CR54", "doi-asserted-by": "publisher", "first-page": "972", "DOI": "10.1245/s10434-009-0327-6", "volume": "16", "author": "F Marchal", "year": "2009", "unstructured": "Marchal F, Salou M, Marchal C, Lesur A, Desandes E (2009) Men with breast cancer have same disease-specific and event-free survival as women. Ann Surg Oncol 16(4):972\u2013978", "journal-title": "Ann Surg Oncol"}, {"issue": "1", "key": "4921_CR55", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1097/00000421-198702000-00013", "volume": "10", "author": "CS Bagley", "year": "1987", "unstructured": "Bagley CS, Wesley MN, Young RC, Lippman ME (1987) Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 10(1):55\u201360", "journal-title": "Am J Clin Oncol"}, {"issue": "4", "key": "4921_CR56", "doi-asserted-by": "publisher", "first-page": "775780", "DOI": "10.1016/S0039-6060(99)70135-2", "volume": "126", "author": "CE Scott-Conner", "year": "1999", "unstructured": "Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ (1999) An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 126(4):775\u2013780 (discussion 780-781)", "journal-title": "Surgery"}, {"issue": "7", "key": "4921_CR57", "first-page": "2370", "volume": "85", "author": "N Mauras", "year": "2000", "unstructured": "Mauras N, O\u2019Brien KO, Klein KO, Hayes V (2000) Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metab 85(7):2370\u20132377", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "2", "key": "4921_CR58", "first-page": "319", "volume": "77", "author": "PF Trunet", "year": "1993", "unstructured": "Trunet PF, Mueller P, Bhatnagar AS, Dickes I, Monnet G, White G (1993) Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 267, in healthy male subjects. J Clin Endocrinol Metab 77(2):319\u2013323", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "5", "key": "4921_CR59", "doi-asserted-by": "publisher", "first-page": "503", "DOI": "10.1111/j.1524-4741.2011.01148.x", "volume": "17", "author": "JV Kiluk", "year": "2011", "unstructured": "Kiluk JV, Lee MC, Park CK, Meade T, Minton S, Harris E et al (2011) Male breast cancer: management and follow-up recommendations. Breast J 17(5):503\u2013509", "journal-title": "Breast J"}, {"issue": "5", "key": "4921_CR60", "doi-asserted-by": "publisher", "first-page": "413", "DOI": "10.1016/j.gyobfe.2006.03.014", "volume": "34", "author": "N Arnould", "year": "2006", "unstructured": "Arnould N, Pouget O, Gharbi M, Brettes JP (2006) Breast cancer in men: are there similarities with breast cancer in women? Gynecol Obstet Fertil 34(5):413\u2013419", "journal-title": "Gynecol Obstet Fertil"}, {"issue": "1", "key": "4921_CR61", "doi-asserted-by": "publisher", "first-page": "74", "DOI": "10.1002/1097-0142(19940701)74:1<74::AID-CNCR2820740113>3.0.CO;2-#", "volume": "74", "author": "TF Anelli", "year": "1994", "unstructured": "Anelli TF, Anelli A, Tran KN, Lebwohl DE, Borgen PI (1994) Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 74(1):74\u201377", "journal-title": "Cancer"}, {"issue": "5", "key": "4921_CR62", "first-page": "17", "volume": "17", "author": "H Visram", "year": "2010", "unstructured": "Visram H, Kanji F, Dent SF (2010) Endocrine therapy for male breast cancer: rates of toxicity and adherence. Curr Oncol 17(5):17\u201321", "journal-title": "Curr Oncol"}, {"issue": "15", "key": "4921_CR63", "doi-asserted-by": "publisher", "first-page": "3558", "DOI": "10.1002/cncr.25153", "volume": "116", "author": "LC Harlan", "year": "2010", "unstructured": "Harlan LC, Zujewski JA, Goodman MT, Stevens JL (2010) Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival. Cancer 116(15):3558\u20133568", "journal-title": "Cancer"}, {"issue": "2", "key": "4921_CR64", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1007/s10549-012-2355-3", "volume": "137", "author": "H Eggemann", "year": "2013", "unstructured": "Eggemann H, Ignatov A, Smith BJ, Altmann U, von Minckwitz G, Rohl FW et al (2013) Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res Treat 137(2):465\u2013470", "journal-title": "Breast Cancer Res Treat"}, {"key": "4921_CR65", "unstructured": "Reinisch M, Seiler S, Hauzenberger T, Schmatloch S, Strittmatter HJ, Zahm DM et al (2017) Male-GBG54: A prospective, randomised, multi-centre, phase II study evaluating endocrine treatment with either tamoxifen +/\u2212 gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients. Presented at the 2017 San Antonio Breast Cancer Symposium. December 5\u20139, 2017: San Antonio, Texas USA. Poster PD7-10"}, {"issue": "12", "key": "4921_CR66", "doi-asserted-by": "publisher", "first-page": "3111", "DOI": "10.1093/annonc/mdx036", "volume": "28", "author": "F Cardoso", "year": "2017", "unstructured": "Cardoso F, Costa A, Senkus E, Aapro M, Andre F, Barrios CH et al (2017) 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). Ann Oncol 28(12):3111", "journal-title": "Ann Oncol"}, {"issue": "6", "key": "4921_CR67", "doi-asserted-by": "publisher", "first-page": "1243", "DOI": "10.1093/annonc/mdp450", "volume": "21", "author": "J Doyen", "year": "2010", "unstructured": "Doyen J, Italiano A, Largillier R, Ferrero JM, Fontana X, Thyss A (2010) Aromatase inhibition in male breast cancer patients: biological and clinical implications. Ann Oncol 21(6):1243\u20131245", "journal-title": "Ann Oncol"}, {"issue": "4", "key": "4921_CR68", "doi-asserted-by": "publisher", "first-page": "985", "DOI": "10.1093/annonc/mdr005", "volume": "22", "author": "G Masci", "year": "2011", "unstructured": "Masci G, Gandini C, Zuradelli M, Pedrazzoli P, Torrisi R, Lutman FR et al (2011) Fulvestrant for advanced male breast cancer patients: a case series. Ann Oncol 22(4):985", "journal-title": "Ann Oncol"}, {"issue": "11", "key": "4921_CR69", "doi-asserted-by": "publisher", "first-page": "1896", "DOI": "10.1093/annonc/mdp413", "volume": "20", "author": "JR Haba Rodr\u00edguez de la", "year": "2009", "unstructured": "de la Haba Rodr\u00edguez JR, Porras Quintela I, Pulido Cortio G, Berciano Guerrero M, Aranda E (2009) Fulvestrant in advanced male breast cancer. Ann Oncol 20(11):1896\u20131897", "journal-title": "Ann Oncol"}, {"issue": "1", "key": "4921_CR70", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1007/s10549-006-9356-z", "volume": "103", "author": "A Agrawal", "year": "2007", "unstructured": "Agrawal A, Ayantunde AA, Rampaul R, Robertson JF (2007) Male breast cancer: a review of clinical management. Breast Cancer Res Treat 103(1):11\u201321", "journal-title": "Breast Cancer Res Treat"}, {"key": "4921_CR71", "unstructured": "Helwick C (2016) Is male breast cancer overlooked in clinical trials? May 25. \n                    http://www.ascopost.com/issues/may-25-2016/is-male-breast-cancer-overlooked-in-clinical-trials/\n                    \n                  . Accessed 12 March 2017"}, {"key": "4921_CR72", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1016/j.ejca.2017.01.034", "volume": "82", "author": "MA Vermeulen", "year": "2017", "unstructured": "Vermeulen MA, Slaets L, Cardoso F, Giordano SH, Tryfonidis K, van Diest PJ et al (2017) Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Eur J Cancer 82:219\u2013227", "journal-title": "Eur J Cancer"}, {"issue": "4", "key": "4921_CR73", "doi-asserted-by": "publisher", "first-page": "509", "DOI": "10.1038/modpathol.2016.229", "volume": "30", "author": "SC Doebar", "year": "2017", "unstructured": "Doebar SC, Slaets L, Cardoso F, Giordano SH, Bartlett JM, Tryfonidis K et al (2017) Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Mod Pathol 30(4):509\u2013518", "journal-title": "Mod Pathol"}, {"key": "4921_CR74", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1186/s13046-015-0143-8", "volume": "34", "author": "L Lauro Di", "year": "2015", "unstructured": "Di Lauro L, Pizzuti L, Barba M, Sergi D, Sperduti I, Mottolese M et al (2015) Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study. J Exp Clin Cancer Res 34:26", "journal-title": "J Exp Clin Cancer Res"}, {"key": "4921_CR75", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1186/s12967-016-1027-1", "volume": "14", "author": "A Papa", "year": "2016", "unstructured": "Papa A, Caruso D, Strudel M, Tomao S, Tomao F (2016) Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment. J Transl Med 14:267", "journal-title": "J Transl Med"}, {"issue": "3", "key": "4921_CR76", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.17219/acem/60848", "volume": "26", "author": "M Stepnik", "year": "2017", "unstructured": "Stepnik M, Spryszynska S, Gorzkiewicz A, Ferlinska M (2017) Cytotoxicity of anticancer drugs and PJ-34 (poly(ADP-ribose)polymerase-1 (PARP-1) inhibitor) on HL-60 and Jurkat cells. Adv Clin Exp Med 26(3):379\u2013385", "journal-title": "Adv Clin Exp Med"}, {"issue": "2", "key": "4921_CR77", "doi-asserted-by": "publisher", "first-page": "198", "DOI": "10.7150/ijbs.17240", "volume": "13", "author": "Y Kim", "year": "2017", "unstructured": "Kim Y, Kim A, Sharip A, Sharip A, Jiang J, Yang Q et al (2017) Reverse the resistance to PARP inhibitors. Int J Biol Sci 13(2):198\u2013208", "journal-title": "Int J Biol Sci"}, {"issue": "4", "key": "4921_CR78", "first-page": "265", "volume": "31", "author": "J Rivero del", "year": "2017", "unstructured": "del Rivero J, Kohn EC (2017) PARP inhibitors: the cornerstone of DNA repair-targeted therapies. Oncology (Williston Park) 31(4):265\u2013273", "journal-title": "Oncology (Williston Park)"}, {"issue": "18", "key": "4921_CR79", "doi-asserted-by": "publisher", "first-page": "1697", "DOI": "10.1056/NEJMoa1506859", "volume": "373", "author": "J Mateo", "year": "2015", "unstructured": "Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R et al (2015) DNA-repair defects and olaparib in metastatic prostate cancer. N Engl J Med 373(18):1697\u20131708", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "4921_CR80", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1007/s12672-017-0314-5", "volume": "9", "author": "JL Christenson", "year": "2018", "unstructured": "Christenson JL, Trepel JB, Haythem YA, Lee S, Eisner JR, Baskni-Bey ES et al (2018) Harnessing a different dependency: how to identify and target androgen receptor-positive versus quadruple-negative breast cancer. Horm Canc 9(2):82\u201394", "journal-title": "Horm Canc"}, {"key": "4921_CR81", "doi-asserted-by": "publisher", "first-page": "45293", "DOI": "10.1038/srep45293", "volume": "7", "author": "MP Humphries", "year": "2017", "unstructured": "Humphries MP, Sundara Rajan S, Honarpisheh H, Cserni G, Dent J, Fulford L et al (2017) Characterisation of male breast cancer: a descriptive biomarker study from a large patient series. Sci Rep 7:45293", "journal-title": "Sci Rep"}, {"issue": "8", "key": "4921_CR82", "doi-asserted-by": "publisher", "first-page": "654", "DOI": "10.1111/iju.13137", "volume": "23", "author": "Y Imamura", "year": "2016", "unstructured": "Imamura Y, Sadar MD (2016) Androgen receptor targeted therapies in castration-resistant prostate cancer: bench to clinic. Int J Urol 23(8):654\u2013665", "journal-title": "Int J Urol"}, {"issue": "19", "key": "4921_CR83", "doi-asserted-by": "publisher", "first-page": "5505", "DOI": "10.1158/1078-0432.CCR-12-3327", "volume": "19", "author": "A Gucalp", "year": "2013", "unstructured": "Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA et al (2013) Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. Clin Cancer Res 19(19):5505\u20135512", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "4921_CR84", "doi-asserted-by": "publisher", "first-page": "R7", "DOI": "10.1186/bcr3599", "volume": "16", "author": "DR Cochrane", "year": "2014", "unstructured": "Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D\u2019Amato NC et al (2014) Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res 16(1):R7", "journal-title": "Breast Cancer Res"}, {"issue": "3", "key": "4921_CR85", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.3390/cancers9030021", "volume": "9", "author": "B Rahim", "year": "2017", "unstructured": "Rahim B, O\u2019Regan R (2017) AR signaling in breast cancer. Cancers (Basel) 9(3):21", "journal-title": "Cancers (Basel)"}, {"key": "4921_CR86", "unstructured": "Traina TA, Miller K, Yardley DA, O\u2019Shaughnessy J, Cortes J, Awada A et al (2015) Results from a Phase 2 study of enzalutamide, an androgen receptor inhibitor, in advanced AR + triple-negative breast cancer (MDV3100-11). Presented at the 2015 American Society of Clinical Oncology annual conference. May 29-June 2, 2015: Chicago, Illinois USA"}, {"key": "4921_CR87", "unstructured": "Yardley DA, Krop I, Abramson V, Colleoni M, Traina T, Holmes F et al. Results from a randomized placebo-controlled phase 2 trial evaluating exemestane \u00b1 enzalutamide in patients with hormone receptor\u2013positive breast cancer. Presented at the 2017 San Antonio Breast Cancer Symposium. December 5\u20139, 2017: San Antonio,Texas USA"}, {"key": "4921_CR88", "unstructured": "Traina TA, Miller K, Yardley DA, O\u2019Shaughnessy J, Cortes J, Awada A et al (2015) Results from a phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR + triple-negative breast cancer (TNBC). J Clin Oncol 33(suppl); abstr 1003", "DOI": "10.1200/jco.2015.33.15_suppl.1003", "doi-asserted-by": "crossref"}, {"key": "4921_CR89", "unstructured": "Pfizer oncology to present data across 13 different types of cancer at ASCO 2017 annual meeting. \n                    http://www.pfizer.com/news/press-release/press-release-detail/pfizer-oncology-to-present-data-across-13-different-types-of-cancer-at-asco-2017-annual-meeting\n                    \n                  . Accessed 13 Dec 2017"}, {"issue": "6", "key": "4921_CR90", "doi-asserted-by": "publisher", "first-page": "2326", "DOI": "10.1172/JCI87328", "volume": "127", "author": "JD Norris", "year": "2017", "unstructured": "Norris JD, Ellison SJ, Baker JG, Stagg DB, Wardell SE, Park S et al (2017) Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer. J Clin Invest 127(6):2326\u20132338", "journal-title": "J Clin Invest"}, {"key": "4921_CR91", "unstructured": "FDA grants fast-track status for Innocrin\u2019s seviteronel to treat metastatic CRPC. January 7 (2016). \n                    http://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-status-innocrins-seviteronel-treat-metastatic-crpc-4770025\n                    \n                  . Accessed 13 March 2017"}, {"key": "4921_CR92", "unstructured": "Innocrin Pharmaceuticals appoints Fred Eshelman, PharmD as CEO and is granted Fast Track designation by FDA for seviteronel treatment of women with triple-negative breast cancer and women or men with estrogen receptor-positive breast cancer. \n                    http://www.innocrinpharma.org/wp-content/uploads/2017/04/Innocrin-Pharmaceuticals-Appoints-Fred-Eshelman.pdf\n                    \n                  . Accessed 13 March 2017"}, {"key": "4921_CR93", "unstructured": "Gucalp A, Bardia A, Gabrail N, DaCosta N, Danso M, Elias AD et al (2016) Phase 1/2 study of oral seviteronel (VT-464), a dual CYP17-lyase inhibitor and androgen receptor (AR) antagonist, in patients with advanced AR positive triple negative (TNBC) or estrogen receptor (ER) positive breast cancer (BC). Presented at the 2016 San Antonio breast cancer symposium. December 6\u201310, 2016: San Antonio, Texas USA. Poster P2-08-04"}, {"key": "#cr-split#-4921_CR94.1", "unstructured": "Elias A, Gucalp A, Gardia A, Resaul A, Eisner J, Baskin-Bey E et al (2017) Men with advanced breast cancer (BC): initial phase"}, {"key": "#cr-split#-4921_CR94.2", "unstructured": "(Ph) 2 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor inhibitor. Presented at the 2017 San Antonio breast cancer symposium. December 5-9, 2017: San Antonio, Texas, USA. Poster P5-23-04"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s10549-018-4921-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-018-4921-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-018-4921-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 8]], "date-time": "2019-10-08T18:18:53Z", "timestamp": 1570558733000}, "score": 33.543972, "issued": {"date-parts": [[2018, 9, 28]]}, "references-count": 95, "journal-issue": {"published-print": {"date-parts": [[2019, 1]]}, "issue": "1"}, "alternative-id": ["4921"], "URL": "http://dx.doi.org/10.1007/s10549-018-4921-9", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}], "assertion": [{"value": "20 July 2018", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "9 August 2018", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "28 September 2018", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with ethical standards"}}, {"value": "Ayca Gucalp receives salary support to conduct clinical trials from Innocrin Pharmaceuticals, Pfizer, Novartis, and Merck. She also received an honorarium for participating on an advisory board for Pfizer. Tiffany A. Traina is a compensated Seviteronel Breast Cancer Steering Committee member (Innocrin Pharmaceuticals) and receives research support from Innocrin Pharmaceuticals for trials of seviteronel. Joel R. Eisner and Edwina S. Baskin-Bey declare that they are employed by and have stock ownership in Innocrin Pharmaceuticals. Joel S. Parker is a compensated advisor to Innocrin Pharmaceuticals and author of the PAM50 patent and related patents for Nanostring Technologies, Inc. Ben H. Park has ownership interest and is a paid member of the scientific advisory board of Loxo Oncology and is a paid consultant for Foundation Medicine, Inc.; Jackson Laboratories; Casdin Capital; and Roche. Under separate licensing agreements between Horizon Discovery, Ltd and The Johns Hopkins University, Ben H. Park is entitled to a share of royalties received by the university on sales of products. The terms of this arrangement are managed by The Johns Hopkins University in accordance with its conflict of interest policies. Fatima Cardoso serves on advisory boards for Amgen, Astellas/Medivation, AstraZeneca, Celgene, Daiichi-Sankyo, Eisai, GE Oncology, Genentech, GlaxoSmithKline, Macrogenics, Merck-Sharp, Merus BV, Mylan, Mundipharma, Novartis, Pfizer, Pierre-Fabre, Roche, Sanofi, Seattle-Genetics, and Teva. All other authors declare that they have no potential conflict of interest.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of interest"}}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T22:02:12Z", "timestamp": 1575151332758}, "reference-count": 21, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 5, 26]], "date-time": "2005-05-26T00:00:00Z", "timestamp": 1117065600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Cancer Res Clin Oncol"], "published-print": {"date-parts": [[2005, 8]]}, "DOI": "10.1007/s00432-005-0678-8", "type": "journal-article", "created": {"date-parts": [[2005, 5, 25]], "date-time": "2005-05-25T11:26:50Z", "timestamp": 1117020410000}, "page": "552-558", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families"], "prefix": "10.1007", "volume": "131", "author": [{"given": "Andrea", "family": "Pietschmann", "sequence": "first", "affiliation": []}, {"given": "Parvin", "family": "Mehdipour", "sequence": "additional", "affiliation": []}, {"given": "Parvin", "family": "Mehdipour", "sequence": "additional", "affiliation": []}, {"given": "Morteza", "family": "Atri", "sequence": "additional", "affiliation": []}, {"given": "Wera", "family": "Hofmann", "sequence": "additional", "affiliation": []}, {"given": "S. Said", "family": "Hosseini-Asl", "sequence": "additional", "affiliation": []}, {"given": "Siegfried", "family": "Scherneck", "sequence": "additional", "affiliation": []}, {"given": "Stefan", "family": "Mundlos", "sequence": "additional", "affiliation": []}, {"given": "Hartmut", "family": "Peters", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 5, 26]]}, "reference": [{"key": "678_CR1", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1007/s004390100505", "volume": "109", "author": "JT den Dunnen", "year": "2001", "unstructured": "den Dunnen JT, Antonarakis E (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121\u2013124", "journal-title": "Hum Genet"}, {"issue": "4", "key": "678_CR2", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1002/humu.10260", "volume": "22", "author": "O Diez", "year": "2003", "unstructured": "Diez O, Osorio A, Duran M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, Vega A, Campos B, Rodriguez-Lopez R, Velasco E, Chaves J, Diaz-Rubio E, Jesus Cruz J, Torres M, Esteban E, Cervantes A, Alonso C, San Roman JM, Gonzalez-Sarmiento R, Miner C, Carracedo A, Eugenia Armengod M, Caldes T, Benitez J, Baiget M (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22(4):301\u2013312", "journal-title": "Hum Mutat"}, {"issue": "44", "key": "678_CR3", "doi-asserted-by": "crossref", "first-page": "6841", "DOI": "10.1038/sj.onc.1205685", "volume": "21", "author": "S Gad", "year": "2002", "unstructured": "Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Pujol P, Frenay M, Gilbert B, Maugard C, Bignon YJ, Chevrier A, Rossi A, Fricker JP, Nguyen TD, Demange L, Aurias A, Bensimon A und Stoppa-Lyonnet D (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21(44):6841\u20136847", "journal-title": "Oncogene"}, {"key": "678_CR4", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/S0304-3835(01)00394-9", "volume": "165", "author": "A Ghaderi", "year": "2001", "unstructured": "Ghaderi A, Talei A, Farjadian S, Mosalaei A, Doroudchi M, Kimura H (2001) Germline BRCA1 mutations in Iranian women with breast cancer. Cancer Lett 165:87\u201394", "journal-title": "Cancer Lett"}, {"key": "678_CR5", "first-page": "1513", "volume": "11", "author": "EL Goode", "year": "2002", "unstructured": "Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risks. Cancer Epidemiol Biomarkers Prev 11:1513\u20131530", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "678_CR6", "doi-asserted-by": "crossref", "first-page": "362", "DOI": "10.1038/81691", "volume": "26", "author": "CS Healey", "year": "2000", "unstructured": "Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA (2000) A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26:362\u2013364", "journal-title": "Nat Genet"}, {"key": "678_CR7", "doi-asserted-by": "crossref", "first-page": "E36", "DOI": "10.1136/jmg.39.7.e36", "volume": "39", "author": "W Hofmann", "year": "2002", "unstructured": "Hofmann W, Wappenschmidt B, Berhane S, Schmutzler R, Scherneck S (2002) Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families. J Med Genet 39:E36", "journal-title": "J Med Genet"}, {"key": "678_CR8", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1126/science.1088759", "volume": "302", "author": "MC King", "year": "2003", "unstructured": "King MC, Marks JH, Mandell JB (2003) Breast and ovarien cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646", "journal-title": "Science"}, {"key": "678_CR9", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1002/humu.10154", "volume": "20", "author": "A Liede", "year": "2002", "unstructured": "Liede A, Narod S (2002) Hereditary breast and ovarian cancer in Asia: Genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413\u2013424", "journal-title": "Hum Mutat"}, {"key": "678_CR10", "doi-asserted-by": "crossref", "first-page": "1427", "DOI": "10.1086/302358", "volume": "64", "author": "X Liu", "year": "1999", "unstructured": "Liu X, Barker DF (1999) Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1. Am J Hum Genet 64:1427\u20131439", "journal-title": "Am J Hum Genet"}, {"key": "678_CR11", "first-page": "185", "volume": "4", "author": "P Mehdipour", "year": "2003", "unstructured": "Mehdipour P, Atri M, Jafarimojarrad E, Hosseini-Asl SS, Javidroozi M (2003) Laddering through pedigrees: family history of malignancies in primary breast cancer patients. Asian Pacific J Cancer Prev 4:185\u2013192", "journal-title": "Asian Pacific J Cancer Prev"}, {"key": "678_CR12", "first-page": "25", "volume": "2", "author": "A Mosavi-Jarrahi", "year": "2001", "unstructured": "Mosavi-Jarrahi A, Mohagheghi MA, Zeraatti H, Mortazavi H (2001) Cancer registration in Iran. Asian Pacific J Cancer Prev (IACR) 2:25\u201329", "journal-title": "Asian Pacific J Cancer Prev (IACR)"}, {"key": "678_CR13", "doi-asserted-by": "crossref", "first-page": "304", "DOI": "10.1002/ajmg.a.10031", "volume": "117A", "author": "R Moslehi", "year": "2003", "unstructured": "Moslehi R, Kariminejad M, Ghaffari V, Narod S (2003) Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome. Am J Med Genet 117A:304\u2013305", "journal-title": "Am J Med Genet"}, {"key": "678_CR14", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1002/humu.10164", "volume": "21", "author": "H Najmabadi", "year": "2003", "unstructured": "Najmabadi H, Neishabury M, Sahebjam F, Kahrizi K, Shafaghati Y, Nikzat N, Jalalvand M, Aminy F, Hashemi S, Moghimi B, Noorian A, Jannati A, Mohammadi M, Javan K (2003) The Iranian Human Mutation Gene Bank: a data and sample resource for worldwide collaborative genetics research. Hum Mutat 21:146\u2013150", "journal-title": "Hum Mutat"}, {"key": "678_CR15", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1186/bcr36", "volume": "2", "author": "S Neuhausen", "year": "2000", "unstructured": "Neuhausen S (2000) Founder populations and their uses for breast cancer genetics. Breast Cancer Res 2:77\u201381", "journal-title": "Breast Cancer Res"}, {"issue": "15", "key": "678_CR16", "doi-asserted-by": "crossref", "first-page": "1242", "DOI": "10.1001/jama.1997.03550150046034", "volume": "278", "author": "D Shattuck-Eidens", "year": "1997", "unstructured": "Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Thomas A (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278(15):1242\u20131250", "journal-title": "JAMA"}, {"key": "678_CR17", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1086/302974", "volume": "67", "author": "The", "year": "2000", "unstructured": "The BRCA1 Exon 13 Duplication Screening Group 2000 (2000) The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 67:207\u2013212", "journal-title": "Am J Hum Genet"}, {"key": "678_CR18", "unstructured": "The Breast Cancer Information Core \u2013 database. (http://www.nchgr.nih.gov/Intramural_research/Lab_transfer/Bic)"}, {"key": "678_CR19", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.1086/318181", "volume": "68", "author": "Thompson", "year": "2001", "unstructured": "Thompson D, Easton D; Breast Cancer Linkage Consortium (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68(2):410\u2013419", "journal-title": "Am J Hum Genet"}, {"key": "678_CR20", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1086/303076", "volume": "67", "author": "MA Unger", "year": "2000", "unstructured": "Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL (2000) Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67:841\u2013850", "journal-title": "Am J Hum Genet"}, {"key": "678_CR21", "doi-asserted-by": "crossref", "first-page": "R6", "DOI": "10.1186/bcr443", "volume": "4", "author": "V Yassaee", "year": "2002", "unstructured": "Yassaee V, Zeinali S, Harirchi I, Jarvandi S, Mohagheghi M, Hornby D, Dalton A (2002) Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res 4:R6", "journal-title": "Breast Cancer Res"}], "container-title": ["Journal of Cancer Research and Clinical Oncology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00432-005-0678-8.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00432-005-0678-8/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00432-005-0678-8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 28]], "date-time": "2019-05-28T22:37:14Z", "timestamp": 1559083034000}, "score": 33.2048, "issued": {"date-parts": [[2005, 5, 26]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2005, 8]]}, "issue": "8"}, "alternative-id": ["678"], "URL": "http://dx.doi.org/10.1007/s00432-005-0678-8", "relation": {"cites": []}, "ISSN": ["0171-5216", "1432-1335"], "issn-type": [{"value": "0171-5216", "type": "print"}, {"value": "1432-1335", "type": "electronic"}], "subject": ["Cancer Research", "Oncology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T23:33:02Z", "timestamp": 1574292782647}, "reference-count": 38, "publisher": "Springer Science and Business Media LLC", "issue": "11", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 5, 15]], "date-time": "2007-05-15T00:00:00Z", "timestamp": 1179187200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Cancer Res Clin Oncol"], "published-print": {"date-parts": [[2007, 9, 8]]}, "DOI": "10.1007/s00432-007-0229-6", "type": "journal-article", "created": {"date-parts": [[2007, 5, 14]], "date-time": "2007-05-14T08:51:17Z", "timestamp": 1179132677000}, "page": "867-874", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast\u2013ovarian cancer families from Kerala, South India"], "prefix": "10.1007", "volume": "133", "author": [{"given": "Vani", "family": "Syamala", "sequence": "first", "affiliation": []}, {"given": "Leelakumari", "family": "Sreeja", "sequence": "additional", "affiliation": []}, {"given": "Volga S.", "family": "Syamala", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Vinodkumar", "sequence": "additional", "affiliation": []}, {"given": "Praveenkumar B.", "family": "Raveendran", "sequence": "additional", "affiliation": []}, {"given": "Hariharan", "family": "Sreedharan", "sequence": "additional", "affiliation": []}, {"given": "Ratheesan", "family": "Kuttappan", "sequence": "additional", "affiliation": []}, {"given": "Lekshmi", "family": "Balakrishnan", "sequence": "additional", "affiliation": []}, {"given": "Ravindran", "family": "Ankathil", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 5, 15]]}, "reference": [{"key": "229_CR1", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1093/hmg/6.1.53", "volume": "6", "author": "G Bignell", "year": "1997", "unstructured": "Bignell G, Micklem G, Stratton MR, Ashworth A, Wooster R (1997) The BRC repeats are conserved in mammalian BRCA2 proteins. Hum Mol Genet 6:53\u201358", "journal-title": "Hum Mol Genet"}, {"key": "229_CR2", "unstructured": "Breast Cancer Information Core, National Center for Human Genome Research, National Institutes of Health (1996) http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic"}, {"key": "229_CR3", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1038/sj.ejhg.5200167", "volume": "6", "author": "J Chen", "year": "1998", "unstructured": "Chen J, Hedman MZ, Arver BW, Sigurdsson S, Eyfjord JE, Lindblom A (1998) BRCA2 germline mutations in Swedish breast cancer families. Eur J Hum Genet 6:134\u2013139", "journal-title": "Eur J Hum Genet"}, {"key": "229_CR4", "doi-asserted-by": "crossref", "first-page": "1244", "DOI": "10.1038/sj.bjc.6601656", "volume": "90", "author": "K Claes", "year": "2004", "unstructured": "Claes K, Poppe B, Coene I, Paepe AD, Messiaen L (2004) BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families. Br J Cancer 90:1244\u20131251", "journal-title": "Br J Cancer"}, {"key": "229_CR5", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1002/ijc.1627", "volume": "97", "author": "M la Hoya de", "year": "2002", "unstructured": "de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodriguez R, Diaz-Rubio E, Benitez J, Devilee P, Caldes T (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. Int J Cancer 97:466\u2013471", "journal-title": "Int J Cancer"}, {"key": "229_CR6", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1038/ng0797-210", "volume": "16", "author": "D Easton", "year": "1997", "unstructured": "Easton D (1997) Breast cancer genes\u2014what are the real risks?. Nat Genet 16:210\u2013211", "journal-title": "Nat Genet"}, {"key": "229_CR7", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1146/annurev.med.49.1.425", "volume": "49", "author": "LW Ellisen", "year": "1998", "unstructured": "Ellisen LW, Haber DA (1998) Hereditary breast cancer. Annu Rev Med 49:425\u2013436", "journal-title": "Annu Rev Med"}, {"key": "229_CR8", "doi-asserted-by": "crossref", "first-page": "676", "DOI": "10.1086/301749", "volume": "62", "author": "D Ford", "year": "1998", "unstructured": "Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676\u2013689", "journal-title": "Am J Hum Genet"}, {"key": "229_CR9", "doi-asserted-by": "crossref", "first-page": "2417", "DOI": "10.1200/JCO.1998.16.7.2417", "volume": "16", "author": "TS Frank", "year": "1998", "unstructured": "Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Thomas A (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16:2417\u20132425", "journal-title": "J Clin Oncol"}, {"key": "229_CR10", "first-page": "313", "volume": "60", "author": "LS Friedman", "year": "1997", "unstructured": "Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60:313\u2013319", "journal-title": "Am J Hum Genet"}, {"key": "229_CR11", "doi-asserted-by": "crossref", "first-page": "10325", "DOI": "10.1073/pnas.90.21.10325", "volume": "90", "author": "A Ganguly", "year": "1993", "unstructured": "Ganguly A, Rock MJ, Prockop DJ (1993) Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 90:10325\u201310329", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "229_CR12", "doi-asserted-by": "crossref", "first-page": "1171", "DOI": "10.1016/S0039-6109(05)70067-0", "volume": "79", "author": "M Gauthier-Villars", "year": "1999", "unstructured": "Gauthier-Villars M, Gad S, Caux V, Pages S, Blandy C, Stoppa-Lyonnet D (1999) Genetic testing for breast cancer predisposition. Surg Clin North Am 79:1171\u201387, xxi", "journal-title": "Surg Clin North Am"}, {"key": "229_CR13", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1038/ng0197-103", "volume": "15", "author": "SA Gayther", "year": "1997", "unstructured": "Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BA, Stratton MR, Easton D (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15:103\u2013105", "journal-title": "Nat Genet"}, {"key": "229_CR14", "doi-asserted-by": "crossref", "first-page": "E12", "DOI": "10.1136/jmg.39.3.e12", "volume": "39", "author": "U Hamann", "year": "2002", "unstructured": "Hamann U, Liu X, Lange S, Ulmer HU, Benner A, Scott RJ (2002) Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany. J Med Genet 39:E12", "journal-title": "J Med Genet"}, {"key": "229_CR15", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1002/1097-0215(20010101)91:1<83::AID-IJC1013>3.0.CO;2-5", "volume": "91", "author": "N Ikeda", "year": "2001", "unstructured": "Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, Noguchi S (2001) Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83\u201388", "journal-title": "Int J Cancer"}, {"key": "229_CR16", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1002/humu.9015", "volume": "19", "author": "US Khoo", "year": "2002", "unstructured": "Khoo US, Chan KY, Cheung AN, Xue WC, Shen DH, Fung KY, Ngan HY, Choy KW, Pang CP, Poon CS, Poon AY, Ozcelik H (2002) Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat 19:307\u2013308", "journal-title": "Hum Mutat"}, {"key": "229_CR17", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1093/jnci/93.16.1215", "volume": "93", "author": "N Loman", "year": "2001", "unstructured": "Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93:1215\u20131223", "journal-title": "J Natl Cancer Inst"}, {"key": "229_CR18", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1038/ng1196-253", "volume": "14", "author": "S Mazoyer", "year": "1996", "unstructured": "Mazoyer S, Dunning AM, Serova O, Dearden J, Puget N, Healey CS, Gayther SA, Mangion J, Stratton MR, Lynch HT, Goldgar DE, Ponder BA, Lenoir GM (1996) A polymorphic stop codon in BRCA2. Nat Genet 14:253\u2013254", "journal-title": "Nat Genet"}, {"key": "229_CR19", "doi-asserted-by": "crossref", "first-page": "6329", "DOI": "10.1038/sj.onc.1207726", "volume": "23", "author": "DM Parkin", "year": "2004", "unstructured": "Parkin DM (2004) International variation. Oncogene 23:6329\u20136340", "journal-title": "Oncogene"}, {"key": "229_CR20", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1054/bjoc.1999.0892", "volume": "82", "author": "T Peelen", "year": "2000", "unstructured": "Peelen T, van Vliet M, Bosch A, Bignell G, Vasen HF, Klijn JG, Meijers-Heijboer H, Stratton M, van Ommen GJ, Cornelisse CJ, Devilee P (2000) Screening for BRCA2 mutations in 81 Dutch breast\u2013ovarian cancer families. Br J Cancer 82:151\u2013156", "journal-title": "Br J Cancer"}, {"key": "229_CR21", "unstructured": "Peixoto A, Salgueiro N, Santos C, Varzim G, Rocha P, Soares MJ, Pereira D, Rodrigues H, Bento MJ, Fraguas A, Moura G, Regateiro F, Castedo S, Teixeira MR (2006) BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families. Fam Cancer [Epub ahead of print]", "DOI": "10.1007/s10689-006-0009-5", "doi-asserted-by": "crossref"}, {"key": "229_CR22", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1146/annurev.genet.32.1.95", "volume": "32", "author": "N Rahman", "year": "1998", "unstructured": "Rahman N, Stratton MR (1998) The genetics of breast cancer susceptibility. Annu Rev Genet 32:95\u2013121", "journal-title": "Annu Rev Genet"}, {"key": "229_CR23", "first-page": "203", "volume": "4", "author": "T Rajkumar", "year": "2003", "unstructured": "Rajkumar T, Soumittra N, Nancy NK, Swaminathan R, Sridevi V, Shanta V (2003) BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India. Asian Pac J Cancer Prev 4:203\u2013208", "journal-title": "Asian Pac J Cancer Prev"}, {"key": "229_CR24", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1016/j.canlet.2005.03.006", "volume": "233", "author": "R Salazar", "year": "2006", "unstructured": "Salazar R, Cruz-Hernandez JJ, Sanchez-Valdivieso E, Rodriguez CA, Gomez-Bernal A, Barco E, Fonseca E, Portugal T, Gonzalez-Sarmiento R (2006) BRCA1\u20132 mutations in breast cancer: identification of nine new variants of BRCA1\u20132 genes in a population from central Western Spain. Cancer Lett 233:172\u2013177", "journal-title": "Cancer Lett"}, {"key": "229_CR25", "unstructured": "Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor"}, {"key": "229_CR26", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1002/humu.9082", "volume": "20", "author": "S Saxena", "year": "2002", "unstructured": "Saxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G, Goldgar DE, Bhatanager D (2002) BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat 20:473\u2013474", "journal-title": "Hum Mutat"}, {"key": "229_CR27", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1186/1471-2350-7-75", "volume": "7", "author": "S Saxena", "year": "2006", "unstructured": "Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil RS, Chintamani C, Aggarwal AK, Sharma VK, Sharma PC, Lenoir G, Goldgar DE, Szabo CI (2006) Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 7:75", "journal-title": "BMC Med Genet"}, {"key": "229_CR28", "doi-asserted-by": "crossref", "first-page": "994", "DOI": "10.1200/JCO.2002.20.4.994", "volume": "20", "author": "HA Shih", "year": "2002", "unstructured": "Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL (2002) BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 20:994\u2013999", "journal-title": "J Clin Oncol"}, {"key": "229_CR29", "doi-asserted-by": "crossref", "first-page": "1529", "DOI": "10.1093/jnci/92.18.1529", "volume": "92", "author": "K Syrjakoski", "year": "2000", "unstructured": "Syrjakoski K, Vahteristo P, Eerola H, Tamminen A, Kivinummi K, Sarantaus L, Holli K, Blomqvist C, Kallioniemi OP, Kainu T, Nevanlinna H (2000) Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 92:1529\u20131531", "journal-title": "J Natl Cancer Inst"}, {"key": "229_CR30", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.1086/318181", "volume": "68", "author": "D Thompson", "year": "2001", "unstructured": "Thompson D, Easton D (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68:410\u2013419", "journal-title": "Am J Hum Genet"}, {"key": "229_CR31", "doi-asserted-by": "crossref", "first-page": "1337", "DOI": "10.1016/S0140-6736(98)03300-5", "volume": "352", "author": "S Thorlacius", "year": "1998", "unstructured": "Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352:1337\u20131339", "journal-title": "Lancet"}, {"key": "229_CR32", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1002/humu.9213", "volume": "23", "author": "MT Valarmathi", "year": "2004", "unstructured": "Valarmathi MT, Sawhney M, Deo SS, Shukla NK, Das SN (2004) Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast\u2013ovarian cancer families. Hum Mutat 23:205", "journal-title": "Hum Mutat"}, {"key": "229_CR33", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1093/hmg/8.3.413", "volume": "8", "author": "TM Wagner", "year": "1999", "unstructured": "Wagner TM, Hirtenlehner K, Shen P, Moeslinger R, Muhr D, Fleischmann E, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Petru E, Ropp E, Langbauer G, Kubista E, Scheiner O, Underhill P, Mountain J, Stierer M, Zielinski C, Oefner P (1999) Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet 8:413\u2013423", "journal-title": "Hum Mol Genet"}, {"key": "229_CR34", "doi-asserted-by": "crossref", "first-page": "31941", "DOI": "10.1074/jbc.272.51.31941", "volume": "272", "author": "AK Wong", "year": "1997", "unstructured": "Wong AK, Pero R, Ormonde PA, Tavtigian SV, Bartel PL (1997) RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 272:31941\u201331944", "journal-title": "J Biol Chem"}, {"key": "229_CR35", "doi-asserted-by": "crossref", "first-page": "2088", "DOI": "10.1126/science.8091231", "volume": "265", "author": "R Wooster", "year": "1994", "unstructured": "Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12\u201313. Science 265:2088\u20132090", "journal-title": "Science"}, {"key": "229_CR36", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1038/378789a0", "volume": "378", "author": "R Wooster", "year": "1995", "unstructured": "Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792", "journal-title": "Nature"}, {"key": "229_CR37", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1054/bjoc.2000.1332", "volume": "83", "author": "H Yazici", "year": "2000", "unstructured": "Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H (2000) BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients. Br J Cancer 83:737\u2013742", "journal-title": "Br J Cancer"}, {"key": "229_CR38", "doi-asserted-by": "crossref", "first-page": "474", "DOI": "10.1002/humu.9083", "volume": "20", "author": "X Zhi", "year": "2002", "unstructured": "Zhi X, Szabo C, Chopin S, Suter N, Wang QS, Ostrander EA, Sinilnikova OM, Lenoir GM, Goldgar D, Shi YR (2002) BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Hum Mutat 20:474", "journal-title": "Hum Mutat"}], "container-title": ["Journal of Cancer Research and Clinical Oncology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00432-007-0229-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00432-007-0229-6/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00432-007-0229-6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 28]], "date-time": "2019-05-28T22:39:43Z", "timestamp": 1559083183000}, "score": 32.76008, "issued": {"date-parts": [[2007, 5, 15]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2007, 9, 8]]}, "issue": "11"}, "alternative-id": ["229"], "URL": "http://dx.doi.org/10.1007/s00432-007-0229-6", "relation": {"cites": []}, "ISSN": ["0171-5216", "1432-1335"], "issn-type": [{"value": "0171-5216", "type": "print"}, {"value": "1432-1335", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T17:14:28Z", "timestamp": 1574874868732}, "reference-count": 61, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2018, 9, 5]], "date-time": "2018-09-05T00:00:00Z", "timestamp": 1536105600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2018, 12]]}, "DOI": "10.1007/s10549-018-4952-2", "type": "journal-article", "created": {"date-parts": [[2018, 9, 5]], "date-time": "2018-09-05T17:35:14Z", "timestamp": 1536168914000}, "page": "539-544", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Surgical options for male breast cancer"], "prefix": "10.1007", "volume": "172", "author": [{"given": "Ian S.", "family": "Fentiman", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 9, 5]]}, "reference": [{"key": "4952_CR1", "doi-asserted-by": "publisher", "first-page": "595", "DOI": "10.1016/S0140-6736(06)68226-3", "volume": "367", "author": "IS Fentiman", "year": "2006", "unstructured": "Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595\u2013604", "journal-title": "Lancet"}, {"key": "4952_CR2", "doi-asserted-by": "publisher", "first-page": "949", "DOI": "10.1007/s10549-011-1856-9", "volume": "133", "author": "AM Shaaban", "year": "2012", "unstructured": "Shaaban AM, Ball GR, Brannan RA et al (2012) A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat 133:949\u2013958", "journal-title": "Breast Cancer Res Treat"}, {"key": "4952_CR3", "doi-asserted-by": "publisher", "first-page": "e1002290", "DOI": "10.1371/journal.pgen.1002290", "volume": "9", "author": "N Orr", "year": "2011", "unstructured": "Orr N, Cooke R, Jones M et al (2011) Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men. PLoS Genet 9:e1002290", "journal-title": "PLoS Genet"}, {"key": "4952_CR4", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1007/s10549-010-1262-8", "volume": "129", "author": "I Johansson", "year": "2011", "unstructured": "Johansson I, Nilsson C, Berglund P et al (2011) High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat 129:747\u2013760", "journal-title": "Breast Cancer Res Treat"}, {"key": "4952_CR5", "first-page": "S6", "volume": "22", "author": "S Piscuoglio", "year": "2014", "unstructured": "Piscuoglio S, Murray M, Ng CKY et al (2014) The genomic landscape of male breast cancer. SABCS 22:S6\u2013S06", "journal-title": "SABCS"}, {"key": "4952_CR6", "doi-asserted-by": "publisher", "first-page": "1233", "DOI": "10.1056/NEJMoa022152", "volume": "347", "author": "B Fisher", "year": "2002", "unstructured": "Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233\u20131241", "journal-title": "N Engl J Med"}, {"key": "4952_CR7", "doi-asserted-by": "publisher", "first-page": "1227", "DOI": "10.1056/NEJMoa020989", "volume": "347", "author": "U Veronesi", "year": "2002", "unstructured": "Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomised study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227\u20131232", "journal-title": "N Engl J Med"}, {"key": "4952_CR8", "doi-asserted-by": "publisher", "first-page": "412", "DOI": "10.1016/S1470-2045(12)70042-6", "volume": "13", "author": "S Liti\u00e8re", "year": "2012", "unstructured": "Liti\u00e8re S, Werutsky G, Fentiman IS et al (2012) Breast conserving therapy versus mastectomy for stage I\u2013II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 13:412\u2013419", "journal-title": "Lancet Oncol"}, {"key": "4952_CR9", "doi-asserted-by": "publisher", "first-page": "2359", "DOI": "10.1002/cncr.21526", "volume": "104", "author": "SH Giordano", "year": "2005", "unstructured": "Giordano SH, Perkins GH, Broglio C, Garcia SG, Middleton LP et al (2005) Adjuvant systemic therapy for male breast carcinoma. Cancer 104:2359\u20132364", "journal-title": "Cancer"}, {"issue": "7", "key": "4952_CR10", "doi-asserted-by": "publisher", "first-page": "e1481", "DOI": "10.7759/cureus.1481", "volume": "9", "author": "D Saha", "year": "2017", "unstructured": "Saha D, Tannenbaum S, Zhu Q (2017) Treatment of male breast cancer by dual human epidermal growth factor receptor 2 (HER2) blockade and response prediction using novel optical tomography imaging: a case report. Cureus 9(7):e1481. \n                    https://doi.org/10.7759/cureus.1481", "journal-title": "Cureus"}, {"key": "4952_CR11", "doi-asserted-by": "publisher", "first-page": "232", "DOI": "10.1200/JCO.2009.23.8162", "volume": "28", "author": "WF Anderson", "year": "2009", "unstructured": "Anderson WF, Jatoi I, Tse J, Rosenberg PS (2009) Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 28:232\u2013239", "journal-title": "J Clin Oncol"}, {"key": "4952_CR12", "doi-asserted-by": "publisher", "first-page": "1135", "DOI": "10.1016/S1470-2045(10)70257-6", "volume": "11", "author": "J Cuzick", "year": "2010", "unstructured": "Cuzick J, Sestak I, Baum M, Buzdar A, Howell A et al (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11:1135\u20131141", "journal-title": "Lancet Oncol"}, {"issue": "1", "key": "4952_CR13", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1023/B:BREA.0000010701.08825.2d", "volume": "83", "author": "WF Anderson", "year": "2004", "unstructured": "Anderson WF, Althuis MD, Brinton LA, Devesa SS (2004) Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83(1):77\u201386", "journal-title": "Breast Cancer Res Treat"}, {"key": "4952_CR14", "doi-asserted-by": "publisher", "first-page": "2359", "DOI": "10.1002/cncr.21526", "volume": "104", "author": "SH Giordano", "year": "2005", "unstructured": "Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP et al (2005) Adjuvant systemic therapy for male breast carcinoma. Cancer 104:2359\u20132364", "journal-title": "Cancer"}, {"key": "4952_CR15", "first-page": "17", "volume": "17", "author": "H Visram", "year": "2010", "unstructured": "Visram H. Kanji F, Dent SF (2010) Endocrine therapy for male breast cancer: rates of toxicity and adherence. Curr Oncol 17:17\u201321", "journal-title": "Curr Oncol"}, {"key": "4952_CR16", "doi-asserted-by": "publisher", "first-page": "3558", "DOI": "10.1002/cncr.25153", "volume": "116", "author": "LC Harlan", "year": "2010", "unstructured": "Harlan LC, Zujewski JA,. Goodman MT, Stevens JL (2010) Breast cancer in men in the US: a population-based study of diagnosis, treatment and survival. Cancer 116:3558\u20133568", "journal-title": "Cancer"}, {"key": "4952_CR17", "author": "H Eggemann", "year": "2017", "unstructured": "Eggemann H, Altmann U, Costa SD, Ignatov AJ (2017) Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer. Cancer Res Clin Oncol. \n                    https://doi.org/10.1007/s00432-017-2539-7", "journal-title": "Cancer Res Clin Oncol", "DOI": "10.1007/s00432-017-2539-7", "doi-asserted-by": "publisher"}, {"key": "4952_CR18", "doi-asserted-by": "publisher", "first-page": "1243", "DOI": "10.1093/annonc/mdp450", "volume": "21", "author": "J Doyen", "year": "2010", "unstructured": "Doyen J, Italiano A, Largillier R, Ferrero JM, Fontana X, Thyss A (2010) Aromatase inhibition in male breast cancer patients: biological and clinical implications. Ann Oncol 21:1243\u20131245", "journal-title": "Ann Oncol"}, {"key": "4952_CR19", "doi-asserted-by": "publisher", "first-page": "74", "DOI": "10.1002/1097-0142(19940701)74:1<74::AID-CNCR2820740113>3.0.CO;2-#", "volume": "74", "author": "TFM Anelli", "year": "1994", "unstructured": "Anelli TFM, Anelli A, Tran KN, Lebwohl DE, Borgen PI (1994) Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 74:74\u201377", "journal-title": "Cancer"}, {"key": "4952_CR20", "doi-asserted-by": "publisher", "first-page": "1842", "DOI": "10.1001/archinte.1991.00400090120021", "volume": "151", "author": "RR Love", "year": "1991", "unstructured": "Love RR, Cameron L, Connell BL, Leventhal H (1991) Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 151:1842\u20131847", "journal-title": "Arch Intern Med"}, {"key": "4952_CR21", "doi-asserted-by": "publisher", "first-page": "495", "DOI": "10.1007/s10549-012-2286-z", "volume": "136", "author": "S Xu", "year": "2012", "unstructured": "Xu S, Yang Y, Tao W, Song Y, Chen Y et al (2012) Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer. Breast Cancer Res Treat 136:495\u2013502", "journal-title": "Breast Cancer Res Treat"}, {"key": "4952_CR22", "doi-asserted-by": "publisher", "first-page": "1337", "DOI": "10.1002/1097-0142(19870915)60:6<1337::AID-CNCR2820600629>3.0.CO;2-C", "volume": "60", "author": "WR Bezwoda", "year": "1987", "unstructured": "Bezwoda WR, Hesdorffer C, Dansey R, De Moor N, Derman DP et al (1987) Breast cancer in men. Clinical features, hormone receptor status, and response to therapy. Cancer 60:1337\u20131340", "journal-title": "Cancer"}, {"key": "4952_CR23", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1186/s13045-015-0147-z", "volume": "8", "author": "L Lauro Di", "year": "2015", "unstructured": "Di Lauro L, Pizzuti L, Barba M, Sergi D, Sperduti I et al (2015) Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis. J Hematol Oncol 8:53\u201358", "journal-title": "J Hematol Oncol"}, {"key": "4952_CR24", "author": "F Cardoso", "year": "2017", "unstructured": "Cardoso F, Bartlett JMS, Slaets L, van Deurzen CH4, van Leeuwen-Stok E et al (2017) Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol. \n                    https://doi.org/10.1093/annonc/mdx651", "journal-title": "Ann Oncol", "DOI": "10.1093/annonc/mdx651", "doi-asserted-by": "publisher"}, {"key": "4952_CR25", "doi-asserted-by": "publisher", "first-page": "45293", "DOI": "10.1038/srep45293", "volume": "7", "author": "MP Humphries", "year": "2017", "unstructured": "Humphries MP, Sundara Rajan S, Honarpisheh H, Cserni G, Dent J et al (2017) Characterisation of male breast cancer: a descriptive biomarker study from a large patient series. Sci Rep 7:45293. \n                    https://doi.org/10.1038/srep45293", "journal-title": "Sci Rep"}, {"key": "4952_CR26", "doi-asserted-by": "publisher", "first-page": "1233", "DOI": "10.1056/NEJMoa022152", "volume": "347", "author": "B Fisher", "year": "2002", "unstructured": "Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233\u20131241", "journal-title": "N Engl J Med"}, {"key": "4952_CR27", "doi-asserted-by": "publisher", "first-page": "1227", "DOI": "10.1056/NEJMoa020989", "volume": "347", "author": "U Veronesi", "year": "2002", "unstructured": "Veronesi U, Cascinelli N, Mariani L, Greco M. Saccozzi R et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227\u20131232", "journal-title": "N Engl J Med"}, {"key": "4952_CR28", "doi-asserted-by": "publisher", "first-page": "412", "DOI": "10.1016/S1470-2045(12)70042-6", "volume": "13", "author": "S Liti\u00e8re", "year": "2012", "unstructured": "Liti\u00e8re S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR et al (2012) Breast conserving therapy versus mastectomy for stage I\u2013II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 13:412\u2013419", "journal-title": "Lancet Oncol"}, {"key": "4952_CR29", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.1038/bjc.1973.185", "volume": "28", "author": "O Scheike", "year": "1973", "unstructured": "Scheike O (1973) Male breast cancer 5. Clinical manifestations in 257 cases in Denmark. Br J Cancer 28:552\u2013561", "journal-title": "Br J Cancer"}, {"key": "4952_CR30", "doi-asserted-by": "publisher", "first-page": "154", "DOI": "10.1002/1097-0142(19930101)71:1<154::AID-CNCR2820710125>3.0.CO;2-#", "volume": "71", "author": "VF Guinee", "year": "1993", "unstructured": "Guinee VF, Olsson H, Moller T, Shallenberger RC, van den Blink JW et al (1993) The prognosis of breast cancer in males. A report of 335 cases. Cancer 71:154\u2013161", "journal-title": "Cancer"}, {"key": "4952_CR31", "doi-asserted-by": "publisher", "first-page": "629", "DOI": "10.1002/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V", "volume": "85", "author": "PE Goss", "year": "1999", "unstructured": "Goss PE, Reid C, Pintilie M, Lim R, Miller N (1999) Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955\u20131996. Cancer 85:629\u2013639", "journal-title": "Cancer"}, {"key": "4952_CR32", "doi-asserted-by": "publisher", "first-page": "246", "DOI": "10.1016/j.critrevonc.2009.04.002", "volume": "73", "author": "B Cutuli", "year": "2010", "unstructured": "Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z et al (2010) Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol 73:246\u2013254", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "4952_CR33", "doi-asserted-by": "publisher", "first-page": "1545", "DOI": "10.1245/s10434-013-2918-5", "volume": "20", "author": "JM Cloyd", "year": "2013", "unstructured": "Cloyd JM, Hernandez-Boussard T, Wapnir IL (2013) Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983\u20132009. Ann Surg Oncol 20:1545\u20131550", "journal-title": "Ann Surg Oncol"}, {"key": "4952_CR34", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1016/j.ijrobp.2013.07.016", "volume": "87", "author": "EC Fields", "year": "2013", "unstructured": "Fields EC, DeWitt P, Fisher CM, Rabinovitch R (2013) Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis. Int J Radiat Oncol Biol Phys 87:747\u2013752", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "4952_CR35", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1016/j.ejca.2016.10.038", "volume": "71", "author": "JP Leone", "year": "2017", "unstructured": "Leone JP, Leone J, Zwenger AO et al (2017) Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: a population-based study. Eur J Cancer 71:7\u201314", "journal-title": "Eur J Cancer"}, {"key": "4952_CR36", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1016/j.clbc.2015.11.005", "volume": "16", "author": "D Zaenger", "year": "2016", "unstructured": "Zaenger D, Rabatic BM, Dasher B, Mourad WF (2016) Is breast conserving therapy a safe modality for early-stage male breast cancer? Clin Breast Cancer 16:101\u2013104", "journal-title": "Clin Breast Cancer"}, {"key": "4952_CR37", "doi-asserted-by": "publisher", "first-page": "344", "DOI": "10.1016/j.clbc.2013.05.004", "volume": "13", "author": "S Fogh", "year": "2013", "unstructured": "Fogh S, Kachnic LA, Goldberg SI, Taghian AG, Powell SN, Hirsch AE (2013) Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation. Clin Breast Cancer 13:344\u2013349", "journal-title": "Clin Breast Cancer"}, {"key": "4952_CR38", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1200/JCO.2006.10.064", "volume": "24", "author": "K Brain", "year": "2006", "unstructured": "Brain K, Williams B, Iredale R, France L, Gray J (2006) Psychological distress in men with breast cancer. J Clin Oncol 24:95\u2013101", "journal-title": "J Clin Oncol"}, {"key": "4952_CR39", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1007/s10549-017-4290-9", "volume": "165", "author": "A Ania Syrowatka", "year": "2017", "unstructured": "Ania Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG et al (2017) Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 165:229\u2013245", "journal-title": "Breast Cancer Res Treat"}, {"key": "4952_CR40", "doi-asserted-by": "publisher", "first-page": "927", "DOI": "10.1002/pon.2001", "volume": "21", "author": "MA Andrykowski", "year": "2012", "unstructured": "Andrykowski MA (2012) Physical and mental health status and health behaviors in male breast cancer survivors: a national, population-based, case-control study. Psycho Oncol 21:927\u2013934", "journal-title": "Psycho Oncol"}, {"key": "4952_CR41", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1016/j.jamcollsurg.2006.06.014", "volume": "203", "author": "JC Boughey", "year": "2006", "unstructured": "Boughey JC, Bedrosian I, Meric-Bernstam F, Ross MI, Kuerer HM et al (2006) Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 203:475\u2013480", "journal-title": "J Am Coll Surg"}, {"key": "4952_CR42", "doi-asserted-by": "publisher", "first-page": "406", "DOI": "10.3816/CBC.2006.n.058", "volume": "7", "author": "JE Rusby", "year": "2006", "unstructured": "Rusby JE, Smith BL, Dominguez FJ, Golshan M (2006) Sentinel lymph node biopsy in men with breast cancer: a report of 31 consecutive procedures and review of the literature. Clin Breast Cancer 7:406\u2013410", "journal-title": "Clin Breast Cancer"}, {"key": "4952_CR43", "doi-asserted-by": "publisher", "first-page": "512", "DOI": "10.1634/theoncologist.12-5-512", "volume": "12", "author": "O Gentilini", "year": "2007", "unstructured": "Gentilini O, Chagas E, Zurrida S, Intra M, De Cicco C et al (2007) Sentinel lymph node biopsy in male patients with early breast cancer. Oncologist 12:512\u2013515", "journal-title": "Oncologist"}, {"key": "4952_CR44", "doi-asserted-by": "publisher", "first-page": "503", "DOI": "10.1111/j.1524-4741.2011.01148.x", "volume": "17", "author": "JV Kiluk", "year": "2011", "unstructured": "Kiluk JV, Lee MC, Park CK, Meade T, Minton S et al (2011) Male breast cancer: management and follow-up recommendations. Breast J 17:503\u2013509", "journal-title": "Breast J"}, {"key": "4952_CR45", "doi-asserted-by": "publisher", "first-page": "616", "DOI": "10.1016/j.jamcollsurg.2007.11.005", "volume": "206", "author": "LW Flynn", "year": "2008", "unstructured": "Flynn LW, Park J, Patil SM, Cody HS III, Port ER (2008) Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg 206:616\u2013621", "journal-title": "J Am Coll Surg"}, {"key": "4952_CR46", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1007/s12282-014-0535-1", "volume": "23", "author": "R Mar\u00e1z", "year": "2014", "unstructured": "Mar\u00e1z R, Boross G, Pap-Szekeres J, Mark\u00f3 L, Rajt\u00e1r M et al (2014) The role of sentinel node biopsy in male breast cancer. Breast Cancer 23:85\u201391", "journal-title": "Breast Cancer"}, {"key": "4952_CR47", "doi-asserted-by": "publisher", "first-page": "370", "DOI": "10.1093/annonc/mds283", "volume": "24", "author": "C Vaysse", "year": "2013", "unstructured": "Vaysse C, Sroussi J, Mallon P, Feron JG, Rivain AL et al (2013) Prediction of axillary lymph node status in male breast carcinoma. Ann Oncol 24:370\u2013376", "journal-title": "Ann Oncol"}, {"issue": "5", "key": "4952_CR48", "doi-asserted-by": "publisher", "first-page": "e20297", "DOI": "10.1371/journal.pone.0020297", "volume": "6", "author": "F Reyal", "year": "2011", "unstructured": "Reyal F, Rouzier R, Depont-Hazelzet B, Bollet MA, Pierga JY et al (2011) The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma. PLoS ONE 6(5):e20297. \n                    https://doi.org/10.1371/journal.pone.0020297", "journal-title": "PLoS ONE"}, {"key": "4952_CR49", "doi-asserted-by": "publisher", "first-page": "3670", "DOI": "10.1200/JCO.2006.08.8013", "volume": "25", "author": "JL Bevilacqua", "year": "2007", "unstructured": "Bevilacqua JL, Kattan MW, Fey JV et al (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 25:3670\u20133679", "journal-title": "J Clin Oncol"}, {"key": "4952_CR50", "first-page": "138", "volume": "84", "author": "P Michel", "year": "1984", "unstructured": "Michel P, Chastel C, Verhelst G, Van Eukem P, Paquet JL et al (1984) Importance of the Limberg triple flap in the surgical treatment of cancer of the breast in the male. Acta Chir Belg 84:138\u2013143", "journal-title": "Acta Chir Belg"}, {"key": "4952_CR51", "doi-asserted-by": "publisher", "first-page": "1615", "DOI": "10.1097/00006534-199810000-00043", "volume": "102", "author": "SL Spear", "year": "1998", "unstructured": "Spear SL, Bowen DG (1998) Breast reconstruction in a male with a transverse rectus abdominis flap. Plast Reconstr Surg 102:1615\u20131617", "journal-title": "Plast Reconstr Surg"}, {"key": "4952_CR52", "first-page": "358", "volume": "19", "author": "P Cagli\u00e1", "year": "1998", "unstructured": "Cagli\u00e1 P, Veroux PF, Cardillo P, Nicosia A, Mio F, Amodeo C (1998) Carcinoma of the male breast: reconstructive technique. G Chir 19:358\u2013362", "journal-title": "G Chir"}, {"key": "4952_CR53", "first-page": "130", "volume": "46", "author": "GO Igun", "year": "2000", "unstructured": "Igun GO (2000) Rectus abdominis myocutaneous flap in reconstruction for advanced male breast cancer: case report. Cent Afr J Med 46:130\u2013132", "journal-title": "Cent Afr J Med"}, {"key": "4952_CR54", "first-page": "2477", "volume": "22", "author": "A Nakao", "year": "2002", "unstructured": "Nakao A, Saito S, Naomoto Y, Matsuoka J, Tanaka N (2002) Deltopectoral flap for reconstruction of male breast after radical mastectomy for cancer in a patient on hemodialysis. Anticancer Res 22:2477\u20131479", "journal-title": "Anticancer Res"}, {"key": "4952_CR55", "doi-asserted-by": "publisher", "first-page": "286210", "DOI": "10.1155/2012/286210", "volume": "2012", "author": "J Yamamura", "year": "2012", "unstructured": "Yamamura J, Masuda N, Kodama Y, Yasojima H, Mizutani M et al (2012) Male breast cancer originating in an accessory mammary gland in the axilla: a case report. Case Rep Med 2012:286210. \n                    https://doi.org/10.1155/2012/286210", "journal-title": "Case Rep Med"}, {"key": "4952_CR56", "doi-asserted-by": "publisher", "first-page": "420", "DOI": "10.5306/wjco.v7.i5.420", "volume": "7", "author": "M Banys-Paluchowski", "year": "2016", "unstructured": "Banys-Paluchowski M, Burandt E, Banys J et al (2016) Male papillary breast cancer treated by wide resection and latissimus dorsi flap reconstruction: a case report and review of the literature. World J Clin Oncol 7:420\u2013424", "journal-title": "World J Clin Oncol"}, {"key": "4952_CR57", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1007/BF01570695", "volume": "16", "author": "P Brenner", "year": "1992", "unstructured": "Brenner P, Berger A, Schneider W, Axmann HD (1992) Male reduction mammoplasty in serious gynecomastias. Aesthet Plast Surg 16:325\u2013330", "journal-title": "Aesthet Plast Surg"}, {"key": "4952_CR58", "doi-asserted-by": "publisher", "first-page": "1733", "DOI": "10.1002/cncr.21353", "volume": "104", "author": "WF Anderson", "year": "2005", "unstructured": "Anderson WF, Devesa SS (2005) In situ male breast carcinoma in the surveillance, epidemiology, and end results database of the National Cancer Institute. Cancer 104:1733\u20131741", "journal-title": "Cancer"}, {"key": "4952_CR59", "doi-asserted-by": "publisher", "first-page": "2139", "DOI": "10.1002/(SICI)1097-0142(19981115)83:10<2139::AID-CNCR12>3.0.CO;2-F", "volume": "83", "author": "AP Hittmair", "year": "1998", "unstructured": "Hittmair AP, Lininger RA, Tavassoli FA (1998) Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma\u2014a preliminary report. Cancer 83:2139\u20132149", "journal-title": "Cancer"}, {"key": "4952_CR60", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1016/S0959-8049(96)00436-4", "volume": "33", "author": "B Cutuli", "year": "1997", "unstructured": "Cutuli B, Dilhuydy JM, De Lafontan B, Berlie J, Lacroze M et al (1997) Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer 33:35\u201338", "journal-title": "Eur J Cancer"}, {"issue": "Suppl 2", "key": "4952_CR61", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.3109/0284186X.2015.1128119", "volume": "55", "author": "MB Jensen", "year": "2016", "unstructured": "Jensen MB, Ejlertsen B, Mouridsen HT, Christiansen P, Danish Breast Cancer Cooperative Group (2016) Improvements in breast cancer survival between 1995 and 2012 in Denmark: the importance of earlier diagnosis and adjuvant treatment. Acta Oncol 55(Suppl 2):24\u201335", "journal-title": "Acta Oncol"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s10549-018-4952-2/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-018-4952-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-018-4952-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 4]], "date-time": "2019-09-04T23:14:40Z", "timestamp": 1567638880000}, "score": 32.41757, "issued": {"date-parts": [[2018, 9, 5]]}, "references-count": 61, "journal-issue": {"published-print": {"date-parts": [[2018, 12]]}, "issue": "3"}, "alternative-id": ["4952"], "URL": "http://dx.doi.org/10.1007/s10549-018-4952-2", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}], "assertion": [{"value": "9 July 2018", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "1 September 2018", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "5 September 2018", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with ethical standards"}}, {"value": "The author declares he has no conflict of interest.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of interest"}}, {"value": "This article does not contain and studies with human participants performed by the author.", "order": 3, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Ethical approval"}}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}